query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_0185_ESMFold_hypothetical_protein	5u94-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5u94-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PASTA kinase PknB in complex with the potential theraputic kinase inhibitor GSK690693.	0.220	285	201	11	295	4	262	1.886E-17	575
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2p-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	6b2p-assembly1.cif.gz_A-2 Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.211	284	197	12	295	4	254	1.571E-16	549
LOKIASV2_0185_ESMFold_hypothetical_protein	1o6y-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1o6y-assembly1.cif.gz_A Catalytic domain of PknB kinase from Mycobacterium tuberculosis	0.208	290	204	5	294	1	258	2.857E-16	546
LOKIASV2_0185_ESMFold_hypothetical_protein	1mru-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1mru-assembly1.cif.gz_A Intracellular Ser/Thr protein kinase domain of Mycobacterium tuberculosis PknB.	0.215	285	200	13	297	7	262	3.185E-16	515
LOKIASV2_0185_ESMFold_hypothetical_protein	3ori-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	3ori-assembly4.cif.gz_D Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 1)	0.216	282	199	16	297	2	256	5.195E-16	504
LOKIASV2_0185_ESMFold_hypothetical_protein	3ort-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3ort-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 6)	0.204	295	207	3	297	1	261	7.198E-16	502
LOKIASV2_0185_ESMFold_hypothetical_protein	3orm-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3orm-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain D76A mutant	0.213	282	200	16	297	2	256	7.198E-16	495
LOKIASV2_0185_ESMFold_hypothetical_protein	2fum-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	2fum-assembly3.cif.gz_C Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	0.201	283	197	12	294	5	252	3.882E-15	492
LOKIASV2_0185_ESMFold_hypothetical_protein	3orp-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3orp-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 5)	0.211	295	207	3	297	1	263	2.022E-15	492
LOKIASV2_0185_ESMFold_hypothetical_protein	2fum-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	2fum-assembly4.cif.gz_D Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	0.212	283	199	12	294	5	257	3.676E-15	489
LOKIASV2_0185_ESMFold_hypothetical_protein	3oro-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3oro-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 4)	0.213	282	205	16	297	3	263	1.174E-15	482
LOKIASV2_0185_ESMFold_hypothetical_protein	3f61-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3f61-assembly1.cif.gz_A Crystal Structure of M. tuberculosis PknB Leu33Asp/Val222Asp double mutant in complex with ADP	0.214	285	197	13	297	9	260	9.974E-16	480
LOKIASV2_0185_ESMFold_hypothetical_protein	1gjo-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1gjo-assembly1.cif.gz_A The FGFr2 tyrosine kinase domain	0.181	298	229	1	298	1	280	1.382E-15	478
LOKIASV2_0185_ESMFold_hypothetical_protein	6i2p-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6i2p-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PknB kinase domain (L33E mutant) in complex with its substrate GarA	0.207	295	213	1	295	2	271	6.817E-16	475
LOKIASV2_0185_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PknB mutant kinase domain in complex with KT5720	0.209	293	206	5	297	1	262	3.676E-15	474
LOKIASV2_0185_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	0.185	283	221	16	298	14	285	1.541E-15	470
LOKIASV2_0185_ESMFold_hypothetical_protein	6i2p-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6i2p-assembly2.cif.gz_B Crystal structure of the Mycobacterium tuberculosis PknB kinase domain (L33E mutant) in complex with its substrate GarA	0.204	283	206	12	294	6	265	1.718E-15	467
LOKIASV2_0185_ESMFold_hypothetical_protein	3orl-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3orl-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 3)	0.215	293	202	5	297	1	258	3.882E-15	463
LOKIASV2_0185_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.177	296	227	1	296	1	277	1.718E-15	463
LOKIASV2_0185_ESMFold_hypothetical_protein	3ork-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3ork-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 2)	0.204	294	206	4	297	4	263	5.094E-15	461
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_A Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.205	296	204	4	299	1	257	1.258E-13	458
LOKIASV2_0185_ESMFold_hypothetical_protein	4eqm-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4eqm-assembly3.cif.gz_C Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	0.247	291	194	9	299	4	262	3.234E-14	455
LOKIASV2_0185_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.172	296	222	1	296	1	269	2.747E-14	446
LOKIASV2_0185_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	0.180	298	221	1	298	1	271	7.058E-15	446
LOKIASV2_0185_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_B Crystal structure of the Mycobacterium tuberculosis PknB mutant kinase domain in complex with KT5720	0.204	294	218	4	297	1	275	2.900E-14	445
LOKIASV2_0185_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain	0.155	291	207	3	293	1	246	4.731E-14	441
LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.182	283	213	16	298	15	275	1.216E-14	441
LOKIASV2_0185_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.184	296	225	3	298	5	281	1.033E-14	441
LOKIASV2_0185_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	0.188	296	224	1	296	9	285	1.431E-14	440
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.205	294	204	4	297	1	258	8.147E-14	439
LOKIASV2_0185_ESMFold_hypothetical_protein	3bgz-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3bgz-assembly1.cif.gz_A Human Pim-1 kinase in complex with diphenyl indole inhibitor VX3	0.198	280	209	16	295	6	267	3.806E-14	438
LOKIASV2_0185_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_C The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.184	298	231	1	298	1	284	1.595E-14	437
LOKIASV2_0185_ESMFold_hypothetical_protein	6agx-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6agx-assembly1.cif.gz_A The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.185	296	230	3	298	3	285	1.033E-14	437
LOKIASV2_0185_ESMFold_hypothetical_protein	4enx-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4enx-assembly1.cif.gz_A Crystal Structure of Pim-1 Kinase in complex with inhibitor (2E,5Z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-nitrobenzylidene)thiazolidin-4-one	0.193	283	203	16	298	2	253	1.192E-13	433
LOKIASV2_0185_ESMFold_hypothetical_protein	4lm5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4lm5-assembly1.cif.gz_A Crystal structure of Pim1 in complex with 2-{4-[(3-aminopropyl)amino]quinazolin-2-yl}phenol (resulting from displacement of SKF86002)	0.198	283	199	16	298	4	252	1.564E-13	432
LOKIASV2_0185_ESMFold_hypothetical_protein	3kxx-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3kxx-assembly1.cif.gz_A Structure of the mutant Fibroblast Growth Factor receptor 1	0.190	301	241	1	299	4	304	4.099E-15	431
LOKIASV2_0185_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B DISEASE LINKED MUTATION IN FGFR	0.188	294	227	3	296	7	287	3.605E-14	430
LOKIASV2_0185_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A Drosophila CaMKII-wt in complex with a fragment of the Eag potassium channel and Mg2+/AMPPN	0.171	282	215	16	297	8	267	2.551E-13	428
LOKIASV2_0185_ESMFold_hypothetical_protein	5n5l-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5n5l-assembly1.cif.gz_A Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and [2-oxo-2-(1H-pyrrol-2-yl)ethyl] 5-bromo-1H-indole-3-carboxylate	0.182	283	207	16	298	6	259	6.208E-14	428
LOKIASV2_0185_ESMFold_hypothetical_protein	4x3f-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4x3f-assembly2.cif.gz_B Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	0.220	297	210	3	299	1	270	1.744E-13	427
LOKIASV2_0185_ESMFold_hypothetical_protein	5ui0-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ui0-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	0.184	294	235	3	296	9	297	2.747E-14	426
LOKIASV2_0185_ESMFold_hypothetical_protein	3cxw-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3cxw-assembly1.cif.gz_A Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand I	0.192	283	204	16	298	6	258	8.147E-14	425
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.200	285	201	13	297	9	260	2.416E-13	424
LOKIASV2_0185_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	0.181	294	228	3	296	2	280	5.880E-14	424
LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.185	283	219	16	298	16	285	3.063E-14	424
LOKIASV2_0185_ESMFold_hypothetical_protein	6l14-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6l14-assembly1.cif.gz_A Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives	0.174	280	218	16	295	6	270	6.921E-14	422
LOKIASV2_0185_ESMFold_hypothetical_protein	4alu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4alu-assembly1.cif.gz_A Benzofuropyrimidinone Inhibitors of Pim-1	0.200	283	203	16	298	6	260	1.258E-13	422
LOKIASV2_0185_ESMFold_hypothetical_protein	2bil-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2bil-assembly1.cif.gz_B The human protein kinase Pim1 in complex with its consensus peptide Pimtide	0.181	283	208	16	298	6	260	1.192E-13	422
LOKIASV2_0185_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	0.175	294	242	3	296	8	301	2.602E-14	422
LOKIASV2_0185_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_C-2	LOKIASV2_0185_ESMFold_hypothetical_protein	4j97-assembly5.cif.gz_C-2 Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	0.194	296	226	1	296	1	281	2.167E-13	421
LOKIASV2_0185_ESMFold_hypothetical_protein	2c3i-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2c3i-assembly1.cif.gz_B CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN I	0.176	280	217	16	295	2	265	1.329E-13	419
LOKIASV2_0185_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B in complex with ADP	0.170	283	216	16	298	7	267	1.744E-13	418
LOKIASV2_0185_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	0.179	298	235	1	298	1	287	9.083E-14	417
LOKIASV2_0185_ESMFold_hypothetical_protein	5m07-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5m07-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A mutant	0.142	292	209	2	293	1	245	3.941E-13	416
LOKIASV2_0185_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain	0.146	292	207	2	293	1	243	4.639E-13	415
LOKIASV2_0185_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_D The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.180	296	242	3	298	3	298	2.900E-14	415
LOKIASV2_0185_ESMFold_hypothetical_protein	7kie-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7kie-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 3	0.186	294	230	3	296	4	287	6.555E-14	414
LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_B Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.183	281	222	16	296	15	287	4.731E-14	414
LOKIASV2_0185_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.159	306	242	5	310	1	289	2.551E-13	413
LOKIASV2_0185_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5hu3-assembly1.cif.gz_A Drosophila CaMKII-D136N in complex with a phosphorylated fragment of the Eag potassium channel and Mg2+/ADP	0.167	283	216	13	295	6	265	1.234E-12	412
LOKIASV2_0185_ESMFold_hypothetical_protein	3vbt-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3vbt-assembly1.cif.gz_A Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase needle screening and inhibitor design	0.185	283	204	16	298	4	254	4.393E-13	412
LOKIASV2_0185_ESMFold_hypothetical_protein	5toe-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5toe-assembly1.cif.gz_A Pim-1 kinase in complex with a 7-azaindole	0.182	281	218	16	296	5	271	1.564E-13	411
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_D Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.198	294	203	4	297	1	254	8.906E-13	410
LOKIASV2_0185_ESMFold_hypothetical_protein	1ql6-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1ql6-assembly1.cif.gz_A THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES	0.201	283	216	16	298	9	279	7.566E-13	409
LOKIASV2_0185_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	0.176	296	231	3	298	2	282	5.880E-14	409
LOKIASV2_0185_ESMFold_hypothetical_protein	5m07-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5m07-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A mutant	0.141	292	209	2	293	1	244	4.393E-13	408
LOKIASV2_0185_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_B Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.206	285	206	13	297	5	264	8.906E-13	408
LOKIASV2_0185_ESMFold_hypothetical_protein	4eqm-assembly6.cif.gz_F	LOKIASV2_0185_ESMFold_hypothetical_protein	4eqm-assembly6.cif.gz_F Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	0.235	286	193	16	301	10	262	3.348E-13	408
LOKIASV2_0185_ESMFold_hypothetical_protein	7uir-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7uir-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1 in complex with ATP	0.170	289	216	10	298	1	261	9.929E-13	407
LOKIASV2_0185_ESMFold_hypothetical_protein	7khk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7khk-assembly1.cif.gz_A Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX9486 (bezuclastinib) in the DFG-in state	0.189	296	232	1	296	3	289	3.171E-13	407
LOKIASV2_0185_ESMFold_hypothetical_protein	1yxs-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1yxs-assembly1.cif.gz_A Crystal Structure of Kinase Pim1 with P123M mutation	0.181	281	219	16	296	6	273	3.171E-13	406
LOKIASV2_0185_ESMFold_hypothetical_protein	4ow8-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	4ow8-assembly1.cif.gz_A-2 Crystal structure of kinase domain of PknA from Mtb	0.225	294	208	4	297	1	270	7.989E-13	406
LOKIASV2_0185_ESMFold_hypothetical_protein	6aar-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6aar-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with purpurin	0.200	275	202	16	290	12	264	2.369E-12	405
LOKIASV2_0185_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_D Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.187	285	207	13	297	5	260	1.107E-12	403
LOKIASV2_0185_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_C Structure of human phosphorylase kinase, gamma 2	0.186	283	219	16	298	15	284	4.639E-13	403
LOKIASV2_0185_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	0.166	285	219	16	300	7	269	6.088E-13	403
LOKIASV2_0185_ESMFold_hypothetical_protein	5m09-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5m09-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136N double mutant	0.136	291	208	3	293	1	242	1.303E-12	402
LOKIASV2_0185_ESMFold_hypothetical_protein	8ie5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8ie5-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with oxyresveratrol	0.200	281	206	16	296	12	269	2.369E-12	402
LOKIASV2_0185_ESMFold_hypothetical_protein	6vzk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6vzk-assembly1.cif.gz_A Crystal structure of human CaMKII-alpha (CAMK2A)kinase domain	0.167	282	207	16	297	7	256	1.234E-12	400
LOKIASV2_0185_ESMFold_hypothetical_protein	7b57-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7b57-assembly1.cif.gz_B Crystal structure of CaMKII-actinin complex bound to ADP	0.172	285	217	16	300	9	271	6.088E-13	400
LOKIASV2_0185_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	0.166	285	219	16	300	2	264	7.566E-13	400
LOKIASV2_0185_ESMFold_hypothetical_protein	5m08-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5m08-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136A double mutant	0.134	294	217	2	295	1	252	4.393E-13	399
LOKIASV2_0185_ESMFold_hypothetical_protein	2v7a-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2v7a-assembly1.cif.gz_A Crystal structure of the T315I Abl mutant in complex with the inhibitor PHA-739358	0.202	282	205	16	297	10	267	2.167E-13	399
LOKIASV2_0185_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A CaMKII Substrate Complex A	0.184	292	218	13	304	6	273	1.652E-13	399
LOKIASV2_0185_ESMFold_hypothetical_protein	4x3f-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4x3f-assembly1.cif.gz_A Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	0.214	294	209	6	299	1	267	8.906E-13	398
LOKIASV2_0185_ESMFold_hypothetical_protein	2py3-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2py3-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565G Mutation Responsible for Pfeiffer Syndrome	0.183	294	227	3	296	2	280	3.941E-13	398
LOKIASV2_0185_ESMFold_hypothetical_protein	5k3y-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5k3y-assembly2.cif.gz_B Crystal structure of AuroraB/INCENP in complex with BI 811283	0.168	298	222	1	298	1	268	6.428E-13	397
LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_C Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.185	281	212	16	296	15	275	3.171E-13	397
LOKIASV2_0185_ESMFold_hypothetical_protein	2vgo-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2vgo-assembly2.cif.gz_B Crystal structure of Aurora B kinase in complex with Reversine inhibitor	0.166	297	220	2	298	3	267	7.566E-13	396
LOKIASV2_0185_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	5vja-assembly1.cif.gz_C Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	0.185	285	210	13	297	5	263	2.244E-12	395
LOKIASV2_0185_ESMFold_hypothetical_protein	2phk-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	2phk-assembly1.cif.gz_A-2 THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION	0.206	281	213	16	296	6	274	2.013E-12	395
LOKIASV2_0185_ESMFold_hypothetical_protein	2iw8-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	2iw8-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	0.201	283	202	16	298	5	258	1.805E-12	394
LOKIASV2_0185_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_B Structure of human phosphorylase kinase, gamma 2	0.196	280	211	16	295	15	278	1.048E-12	394
LOKIASV2_0185_ESMFold_hypothetical_protein	2oiq-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2oiq-assembly2.cif.gz_B Crystal Structure of chicken c-Src kinase domain in complex with the cancer drug imatinib.	0.190	285	200	16	300	10	257	4.019E-14	393
LOKIASV2_0185_ESMFold_hypothetical_protein	4x3f-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4x3f-assembly3.cif.gz_C Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	0.215	295	206	5	299	1	264	1.619E-12	393
LOKIASV2_0185_ESMFold_hypothetical_protein	2qg5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2qg5-assembly1.cif.gz_A Cryptosporidium parvum calcium dependent protein kinase cgd7_1840	0.184	284	210	16	299	26	283	1.841E-13	392
LOKIASV2_0185_ESMFold_hypothetical_protein	5m08-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5m08-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136A double mutant	0.137	294	211	2	295	1	246	1.906E-12	391
LOKIASV2_0185_ESMFold_hypothetical_protein	4c59-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4c59-assembly1.cif.gz_A Structure of GAK kinase in complex with nanobody (NbGAK_4)	0.185	295	208	7	301	4	259	8.435E-13	389
LOKIASV2_0185_ESMFold_hypothetical_protein	5fm3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5fm3-assembly1.cif.gz_A Crystal structure of hyper-phosphorylated RET kinase domain with (proximal) juxtamembrane segment	0.195	294	220	3	296	6	279	2.694E-13	389
LOKIASV2_0185_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B Crystal structure of the autoinhibited form of mouse DAPK2 in complex with ATP	0.208	283	209	16	298	11	275	4.393E-13	389
LOKIASV2_0185_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_A Crystal structure of the human cyclin G associated kinase (GAK)	0.170	296	211	6	301	5	259	8.906E-13	388
LOKIASV2_0185_ESMFold_hypothetical_protein	4j97-assembly6.cif.gz_D-3	LOKIASV2_0185_ESMFold_hypothetical_protein	4j97-assembly6.cif.gz_D-3 Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.	0.175	296	232	3	298	4	285	7.166E-13	388
LOKIASV2_0185_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_B Crystal structure of the human cyclin G associated kinase (GAK)	0.188	296	212	6	301	4	265	9.929E-13	387
LOKIASV2_0185_ESMFold_hypothetical_protein	7ozy-assembly1.cif.gz_AAA	LOKIASV2_0185_ESMFold_hypothetical_protein	7ozy-assembly1.cif.gz_AAA FGFR2 kinase domain (residues 461-763) in complex with 38.	0.167	295	232	1	295	1	280	7.166E-13	387
LOKIASV2_0185_ESMFold_hypothetical_protein	4ypd-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4ypd-assembly1.cif.gz_A Crystal Structure of DAPK1 catalytic domain in complex with the hinge binding fragment 4-methylpyridazine	0.204	280	208	16	295	12	273	3.109E-12	387
LOKIASV2_0185_ESMFold_hypothetical_protein	7xzr-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7xzr-assembly1.cif.gz_A Crystal structure of TNIK-AMPPNP-thiopeptide TP15 complex	0.177	286	220	16	301	14	281	4.898E-13	386
LOKIASV2_0185_ESMFold_hypothetical_protein	3el8-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3el8-assembly2.cif.gz_B Crystal structure of c-Src in complex with pyrazolopyrimidine 5	0.181	285	196	16	300	12	251	5.172E-13	385
LOKIASV2_0185_ESMFold_hypothetical_protein	4b4l-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4b4l-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT	0.210	283	209	16	298	9	273	1.107E-12	385
LOKIASV2_0185_ESMFold_hypothetical_protein	4c57-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4c57-assembly2.cif.gz_B Structure of GAK kinase in complex with a nanobody	0.189	298	239	6	301	3	300	1.841E-13	385
LOKIASV2_0185_ESMFold_hypothetical_protein	7uiq-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7uiq-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1	0.173	283	211	16	298	6	261	4.803E-12	383
LOKIASV2_0185_ESMFold_hypothetical_protein	6fha-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6fha-assembly1.cif.gz_A Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289A and S308A mutations	0.202	283	211	16	298	10	274	2.125E-12	383
LOKIASV2_0185_ESMFold_hypothetical_protein	7oai-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7oai-assembly1.cif.gz_A Crystal structure of pseudokinase CASK in complex with PFE-PKIS12	0.199	285	215	16	300	8	276	3.864E-12	383
LOKIASV2_0185_ESMFold_hypothetical_protein	5tur-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5tur-assembly1.cif.gz_A Pim-1 kinase in complex with a 7-azaindole	0.178	281	217	16	296	5	269	1.234E-12	382
LOKIASV2_0185_ESMFold_hypothetical_protein	3f5g-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3f5g-assembly1.cif.gz_A Crystal structure of death associated protein kinase in complex with ADP and Mg2+	0.209	280	206	16	295	12	272	4.549E-12	382
LOKIASV2_0185_ESMFold_hypothetical_protein	4i5p-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4i5p-assembly1.cif.gz_A Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain	0.180	280	211	8	287	1	258	1.303E-12	381
LOKIASV2_0185_ESMFold_hypothetical_protein	7aaz-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7aaz-assembly1.cif.gz_A Crystal structure of MerTK in complex with a type 1.5 aminopyridine inhibitor	0.179	281	223	16	296	14	286	9.404E-13	381
LOKIASV2_0185_ESMFold_hypothetical_protein	3ckx-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3ckx-assembly1.cif.gz_A Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine	0.236	284	192	16	299	5	256	3.535E-13	380
LOKIASV2_0185_ESMFold_hypothetical_protein	4fg7-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4fg7-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-293 in complex with ATP	0.201	281	189	16	296	12	249	5.071E-12	379
LOKIASV2_0185_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24	0.170	285	234	16	298	3	287	1.805E-12	379
LOKIASV2_0185_ESMFold_hypothetical_protein	3f3z-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	3f3z-assembly1.cif.gz_A-2 Crystal structure of Cryptosporidium parvum calcium dependent protein kinase cgd7_1840 in presence of indirubin E804	0.208	293	207	16	308	6	267	1.805E-12	378
LOKIASV2_0185_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_D Structure of human phosphorylase kinase, gamma 2	0.196	283	214	16	298	15	281	2.244E-12	378
LOKIASV2_0185_ESMFold_hypothetical_protein	3d5w-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3d5w-assembly1.cif.gz_A Crystal structure of a phosphorylated Polo-like kinase 1 (Plk1) catalytic domain in complex with ADP.	0.177	279	208	2	280	1	254	2.641E-12	376
LOKIASV2_0185_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A Crystal structure of CK2a1 H160A with hematein	0.185	287	229	16	297	38	324	7.566E-13	376
LOKIASV2_0185_ESMFold_hypothetical_protein	5u6c-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5u6c-assembly1.cif.gz_A Crystal structure of the Mer kinase domain in complex with a macrocyclic inhibitor	0.206	282	200	16	297	16	268	1.048E-12	375
LOKIASV2_0185_ESMFold_hypothetical_protein	2a27-assembly4.cif.gz_H	LOKIASV2_0185_ESMFold_hypothetical_protein	2a27-assembly4.cif.gz_H Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 8 monomers in the asymmetric unit	0.208	283	209	16	298	12	276	1.169E-12	375
LOKIASV2_0185_ESMFold_hypothetical_protein	6in4-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6in4-assembly1.cif.gz_A Crystal structure of apo DAPK1 in the presence of 18-crown-6	0.202	280	200	16	295	12	262	1.424E-11	374
LOKIASV2_0185_ESMFold_hypothetical_protein	7avy-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7avy-assembly1.cif.gz_A MerTK kinase domain in complex with quinazoline-based inhbitor	0.197	288	209	10	297	7	267	4.080E-12	374
LOKIASV2_0185_ESMFold_hypothetical_protein	4k18-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4k18-assembly1.cif.gz_A Structure of PIM-1 kinase bound to 5-(4-cyanobenzyl)-N-(4-fluorophenyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxamide	0.183	280	217	16	295	7	273	2.244E-12	374
LOKIASV2_0185_ESMFold_hypothetical_protein	6qmo-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6qmo-assembly1.cif.gz_A Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289E and S308A mutations	0.204	282	209	16	297	10	273	2.369E-12	374
LOKIASV2_0185_ESMFold_hypothetical_protein	5u6b-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	5u6b-assembly4.cif.gz_D Structure of the Axl kinase domain in complex with a macrocyclic inhibitor	0.180	283	217	16	298	25	290	2.945E-12	373
LOKIASV2_0185_ESMFold_hypothetical_protein	4b6l-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4b6l-assembly1.cif.gz_A Discovery of Oral Polo-Like Kinase (PLK) Inhibitors with Enhanced Selectivity Profile using Residue Targeted Drug Design	0.175	289	216	9	297	2	264	5.354E-12	372
LOKIASV2_0185_ESMFold_hypothetical_protein	5xka-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5xka-assembly1.cif.gz_B Crystal structure of M.tuberculosis PknI kinase domain	0.164	295	208	3	297	1	250	2.013E-12	370
LOKIASV2_0185_ESMFold_hypothetical_protein	6e6e-assembly6.cif.gz_F	LOKIASV2_0185_ESMFold_hypothetical_protein	6e6e-assembly6.cif.gz_F DGY-06-116, a novel and selective covalent inhibitor of SRC kinase	0.184	285	202	16	300	10	258	1.169E-12	370
LOKIASV2_0185_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	0.190	282	208	16	297	10	267	5.461E-13	370
LOKIASV2_0185_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E Crystal structure of CASK-CaMK in complex with Mint1-CID	0.200	285	214	16	300	7	275	8.733E-12	370
LOKIASV2_0185_ESMFold_hypothetical_protein	4mxz-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4mxz-assembly2.cif.gz_B Src M314L T338M double mutant bound to kinase inhibitor bosutinib	0.196	285	198	16	300	10	256	7.566E-13	369
LOKIASV2_0185_ESMFold_hypothetical_protein	3eid-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3eid-assembly1.cif.gz_A CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	0.178	283	229	16	298	4	283	2.125E-12	369
LOKIASV2_0185_ESMFold_hypothetical_protein	5y80-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5y80-assembly1.cif.gz_A Complex structure of cyclin G-associated kinase with gefitinib	0.196	304	240	6	309	6	304	5.766E-13	369
LOKIASV2_0185_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I	LOKIASV2_0185_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I crystal structure of P-TEFb complex with AFF4 and Tat	0.192	295	228	16	298	12	306	1.107E-12	369
LOKIASV2_0185_ESMFold_hypothetical_protein	3d15-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3d15-assembly1.cif.gz_A Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with 1-(3-chloro-phenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)- ethyl]-thiazol-2-yl}-urea [SNS-314]	0.164	291	212	8	298	1	254	4.549E-12	368
LOKIASV2_0185_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	0.167	296	232	8	303	1	279	1.376E-12	368
LOKIASV2_0185_ESMFold_hypothetical_protein	2owb-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2owb-assembly1.cif.gz_A Structure of the Catalytic Domain of Human Polo-like Kinase 1	0.183	286	213	1	286	1	262	5.354E-12	368
LOKIASV2_0185_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A Crystal Structure of maize CK2 in complex with the inhibitor apigenin	0.168	292	234	16	297	33	324	5.461E-13	368
LOKIASV2_0185_ESMFold_hypothetical_protein	4c58-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	4c58-assembly1.cif.gz_A-2 Structure of GAK kinase in complex with nanobody (NbGAK_4)	0.176	295	211	7	301	4	260	6.303E-12	367
LOKIASV2_0185_ESMFold_hypothetical_protein	5x1s-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5x1s-assembly1.cif.gz_A PpkA-294 with Amppcp	0.225	291	216	1	291	1	280	1.085E-11	367
LOKIASV2_0185_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.186	281	202	16	296	11	259	2.200E-11	367
LOKIASV2_0185_ESMFold_hypothetical_protein	2x0g-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2x0g-assembly1.cif.gz_A X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX	0.212	283	209	16	298	11	276	6.655E-12	367
LOKIASV2_0185_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_B-2	LOKIASV2_0185_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_B-2 Crystal structure of Cka1p, a casein kinase 2 alpha ortholog from Candida albicans	0.182	282	230	16	297	39	320	1.169E-12	367
LOKIASV2_0185_ESMFold_hypothetical_protein	7n3u-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7n3u-assembly1.cif.gz_A Crystal structure of human WEE1 kinase domain in complex with ZN-c3	0.153	274	211	16	289	7	256	2.084E-11	365
LOKIASV2_0185_ESMFold_hypothetical_protein	5lvl-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5lvl-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Compound PS653 Bound to the ATP-Binding Site	0.169	266	202	16	281	9	252	7.419E-12	365
LOKIASV2_0185_ESMFold_hypothetical_protein	5li1-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5li1-assembly1.cif.gz_A Structure of a Par3-inhibitory peptide bound to PKCiota core kinase domain	0.156	289	232	9	297	3	278	4.803E-12	363
LOKIASV2_0185_ESMFold_hypothetical_protein	3ion-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3ion-assembly1.cif.gz_A PDK1 in complex with Compound 8h	0.162	295	210	16	310	8	259	3.864E-12	362
LOKIASV2_0185_ESMFold_hypothetical_protein	4y8d-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4y8d-assembly2.cif.gz_B Crystal structure of Cyclin-G associated kinase (GAK) complexed with selective 12i inhibitor	0.172	295	208	7	301	4	255	1.028E-11	361
LOKIASV2_0185_ESMFold_hypothetical_protein	3vf9-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3vf9-assembly1.cif.gz_A Crystal Structure of Spleen Tyrosine Kinase Syk Catalytic Domain with Thienopyrazolylindole Inhibitor 027	0.179	282	209	16	297	7	262	2.590E-11	361
LOKIASV2_0185_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-3	0.162	295	212	16	310	11	264	7.419E-12	360
LOKIASV2_0185_ESMFold_hypothetical_protein	2pzp-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2pzp-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K526E Mutation Responsible for Crouzon Syndrome	0.190	267	207	30	296	22	278	3.109E-12	360
LOKIASV2_0185_ESMFold_hypothetical_protein	2pvy-assembly1.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	2pvy-assembly1.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome.	0.167	280	232	20	298	6	285	2.502E-12	360
LOKIASV2_0185_ESMFold_hypothetical_protein	3eid-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	3eid-assembly2.cif.gz_C CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	0.186	283	226	16	298	4	282	3.283E-12	360
LOKIASV2_0185_ESMFold_hypothetical_protein	7avx-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7avx-assembly2.cif.gz_B MerTK kinase domain in complex with NPS-1034	0.202	281	199	16	296	11	260	7.027E-12	359
LOKIASV2_0185_ESMFold_hypothetical_protein	3bht-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	3bht-assembly2.cif.gz_C Structure of phosphorylated Thr160 CDK2/cyclin A in complex with the inhibitor meriolin 3	0.194	283	208	16	298	5	263	2.200E-11	359
LOKIASV2_0185_ESMFold_hypothetical_protein	4j7b-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4j7b-assembly2.cif.gz_D Crystal structure of polo-like kinase 1	0.150	298	220	1	298	4	263	2.590E-11	359
LOKIASV2_0185_ESMFold_hypothetical_protein	4csv-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4csv-assembly1.cif.gz_A Tyrosine kinase AS - a common ancestor of Src and Abl bound to Gleevec	0.176	277	190	16	292	9	240	5.354E-12	358
LOKIASV2_0185_ESMFold_hypothetical_protein	2wqn-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2wqn-assembly1.cif.gz_A Structure of ADP-bound human Nek7	0.183	295	209	3	297	1	257	6.526E-11	358
LOKIASV2_0185_ESMFold_hypothetical_protein	3o0g-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3o0g-assembly1.cif.gz_A Crystal Structure of Cdk5:p25 in complex with an ATP analogue	0.160	285	237	16	298	4	288	6.655E-12	358
LOKIASV2_0185_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	0.190	286	228	16	297	6	291	1.710E-12	358
LOKIASV2_0185_ESMFold_hypothetical_protein	3mfu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3mfu-assembly1.cif.gz_A CASK-4M CaM Kinase Domain, AMPPNP-Mn2+	0.193	285	216	16	300	8	276	4.803E-12	358
LOKIASV2_0185_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B Calcium-Dependent Protein Kinase from Eimeria tenella	0.194	297	219	13	309	20	292	4.898E-13	357
LOKIASV2_0185_ESMFold_hypothetical_protein	3brb-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3brb-assembly2.cif.gz_B Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with ADP	0.199	282	204	16	297	13	268	3.466E-12	356
LOKIASV2_0185_ESMFold_hypothetical_protein	2i40-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2i40-assembly1.cif.gz_A Cdk2/Cyclin A complexed with a thiophene carboxamide inhibitor	0.179	283	228	16	298	4	282	9.736E-12	356
LOKIASV2_0185_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10-ATP-gamma-S Complex	0.190	288	228	16	297	6	293	2.789E-12	356
LOKIASV2_0185_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ig1-assembly1.cif.gz_A Crystal structure of S. rosetta CaMKII kinase domain	0.174	285	220	16	300	11	277	4.803E-12	356
LOKIASV2_0185_ESMFold_hypothetical_protein	2wtw-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2wtw-assembly1.cif.gz_A Aurora-A Inhibitor Structure (2nd crystal form)	0.155	283	209	16	298	6	253	1.210E-11	355
LOKIASV2_0185_ESMFold_hypothetical_protein	5de2-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5de2-assembly2.cif.gz_B Structural mechanism of Nek7 activation by Nek9-induced dimerisation	0.178	283	202	16	298	15	261	2.888E-11	355
LOKIASV2_0185_ESMFold_hypothetical_protein	7aw3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7aw3-assembly1.cif.gz_A MerTK kinase domain with type 1 inhibitor from a DNA-encoded library	0.175	287	207	10	296	15	266	2.945E-12	355
LOKIASV2_0185_ESMFold_hypothetical_protein	2x6d-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2x6d-assembly1.cif.gz_A Aurora-A bound to an inhibitor	0.151	291	214	8	298	1	253	1.974E-11	354
LOKIASV2_0185_ESMFold_hypothetical_protein	5yvc-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5yvc-assembly1.cif.gz_A Structure of CaMKK2 in complex with CKI-012	0.180	279	206	10	288	1	252	1.028E-11	354
LOKIASV2_0185_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.191	285	221	16	300	2	275	5.071E-12	354
LOKIASV2_0185_ESMFold_hypothetical_protein	3orz-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	3orz-assembly3.cif.gz_C PDK1 mutant bound to allosteric disulfide fragment activator 2A2	0.164	265	195	16	280	9	242	7.419E-12	354
LOKIASV2_0185_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A Crystal structure of P8C9 bound to CK2alpha	0.188	286	227	16	296	52	337	2.789E-12	354
LOKIASV2_0185_ESMFold_hypothetical_protein	7m5z-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7m5z-assembly1.cif.gz_A Crystal Structure of the MerTK Kinase Domain in Complex with Inhibitor MIPS15692	0.192	282	202	16	297	11	261	8.733E-12	353
LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly1.cif.gz_A Crystal structure of Nek7 SRS mutant bound to compound 51	0.192	282	204	16	297	14	267	2.084E-11	353
LOKIASV2_0185_ESMFold_hypothetical_protein	7olv-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7olv-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor containing a di-methyl, cyano pyrazole group	0.179	281	204	16	296	21	270	1.085E-11	353
LOKIASV2_0185_ESMFold_hypothetical_protein	2g2f-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2g2f-assembly1.cif.gz_A A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	0.190	282	208	16	297	11	268	2.244E-12	353
LOKIASV2_0185_ESMFold_hypothetical_protein	1uu7-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1uu7-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-2	0.161	295	216	16	310	10	267	2.641E-12	353
LOKIASV2_0185_ESMFold_hypothetical_protein	3bqr-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	3bqr-assembly1.cif.gz_A-2 Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with an imidazo-pyridazine ligand	0.195	281	208	16	296	7	266	8.271E-12	352
LOKIASV2_0185_ESMFold_hypothetical_protein	7avx-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7avx-assembly1.cif.gz_A MerTK kinase domain in complex with NPS-1034	0.204	281	209	16	296	11	273	7.419E-12	352
LOKIASV2_0185_ESMFold_hypothetical_protein	3orz-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	3orz-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment activator 2A2	0.171	266	195	16	281	10	245	7.834E-12	352
LOKIASV2_0185_ESMFold_hypothetical_protein	4eol-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4eol-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	0.195	283	226	16	298	5	286	3.660E-12	352
LOKIASV2_0185_ESMFold_hypothetical_protein	6l22-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6l22-assembly1.cif.gz_A Crystal structure of CK2a1 H115Y with hematein	0.195	296	234	16	307	38	333	5.172E-13	352
LOKIASV2_0185_ESMFold_hypothetical_protein	6l8l-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6l8l-assembly4.cif.gz_D C-Src in complex with ibrutinib	0.183	285	198	16	300	6	248	8.733E-12	351
LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_A Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.160	277	207	16	292	12	259	1.124E-10	351
LOKIASV2_0185_ESMFold_hypothetical_protein	7ab2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7ab2-assembly1.cif.gz_A Crystal structure of MerTK kinase domain in complex with UNC2025	0.184	287	206	10	296	15	267	9.221E-12	351
LOKIASV2_0185_ESMFold_hypothetical_protein	3d5u-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3d5u-assembly1.cif.gz_A Crystal structure of a wildtype Polo-like kinase 1 (Plk1) catalytic domain.	0.166	281	214	1	281	1	258	1.770E-11	351
LOKIASV2_0185_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_A-2 Crystal structure of Cka1p, a casein kinase 2 alpha ortholog from Candida albicans	0.196	284	227	16	298	40	323	2.945E-12	351
LOKIASV2_0185_ESMFold_hypothetical_protein	5vdk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5vdk-assembly1.cif.gz_A Crystal structure of human WEE2 kinase domain in complex with MK1775	0.166	276	204	16	291	9	254	2.590E-11	350
LOKIASV2_0185_ESMFold_hypothetical_protein	1oi9-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1oi9-assembly1.cif.gz_A Structure of human Thr160-phospho CDK2/cyclin A complexed with a 6-cyclohexylmethyloxy-2-anilino-purine inhibitor	0.173	284	233	16	298	5	288	1.770E-11	350
LOKIASV2_0185_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form II	0.162	299	246	16	309	26	324	1.453E-12	350
LOKIASV2_0185_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A Crystal structure of Arabidopsis thaliana CK2-alpha-1 in complex with TTP-22	0.169	299	243	16	309	31	329	8.435E-13	350
LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_F	LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_F Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.174	283	208	16	298	13	265	4.224E-11	349
LOKIASV2_0185_ESMFold_hypothetical_protein	6fvg-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6fvg-assembly1.cif.gz_A The Structure of CK2alpha with CCh507 bound	0.193	288	228	16	298	37	324	3.864E-12	349
LOKIASV2_0185_ESMFold_hypothetical_protein	6l23-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6l23-assembly1.cif.gz_A Crystal structure of CK2a1 V116I with hematein	0.188	296	236	16	307	38	333	2.945E-12	349
LOKIASV2_0185_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B CDPK1 from Eimeria tenella in complex with inhibitor UW1521	0.210	284	202	13	296	19	275	2.084E-11	349
LOKIASV2_0185_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.190	284	221	16	299	3	276	2.323E-11	348
LOKIASV2_0185_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.187	284	223	16	299	3	277	6.303E-12	348
LOKIASV2_0185_ESMFold_hypothetical_protein	8b54-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	8b54-assembly2.cif.gz_C CDK2/cyclin A2 in complex with pyrazolo[4,3-d]pyrimidine inhibitor LGR6768	0.182	283	231	16	298	4	286	1.424E-11	348
LOKIASV2_0185_ESMFold_hypothetical_protein	3g2f-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3g2f-assembly2.cif.gz_B Crystal structure of the kinase domain of bone morphogenetic protein receptor type II (BMPR2) at 2.35 A resolution	0.181	288	229	16	296	6	293	2.244E-12	348
LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly3.cif.gz_C Crystal structure of Nek7 SRS mutant bound to compound 51	0.159	294	215	4	297	1	257	1.187E-10	347
LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_D Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.159	280	187	16	295	12	234	1.736E-10	346
LOKIASV2_0185_ESMFold_hypothetical_protein	7kx8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7kx8-assembly1.cif.gz_A Crystal structure of DCLK1-Cter in complex with FMF-03-055-1	0.201	286	195	13	298	7	251	3.399E-11	346
LOKIASV2_0185_ESMFold_hypothetical_protein	2r7b-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2r7b-assembly1.cif.gz_A Crystal Structure of the Phosphoinositide-dependent Kinase-1 (PDK-1)Catalytic Domain bound to a dibenzonaphthyridine inhibitor	0.168	266	193	16	281	8	240	1.424E-11	346
LOKIASV2_0185_ESMFold_hypothetical_protein	4j7b-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4j7b-assembly1.cif.gz_A Crystal structure of polo-like kinase 1	0.160	298	218	1	298	6	266	5.853E-11	346
LOKIASV2_0185_ESMFold_hypothetical_protein	3db6-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3db6-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 902	0.167	280	213	2	281	1	257	3.049E-11	346
LOKIASV2_0185_ESMFold_hypothetical_protein	4eok-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4eok-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor NU6102	0.195	283	225	16	298	5	285	4.080E-12	346
LOKIASV2_0185_ESMFold_hypothetical_protein	4d2t-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4d2t-assembly4.cif.gz_D Structure of MELK in complex with inhibitors	0.184	286	204	16	301	9	259	6.303E-12	346
LOKIASV2_0185_ESMFold_hypothetical_protein	6lnm-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6lnm-assembly1.cif.gz_A Crystal structure of CASK-CaMK in complex with Mint1-CID	0.205	285	213	16	300	7	275	1.028E-11	346
LOKIASV2_0185_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with compound 2 (AA-CS-9-003)	0.193	282	225	16	295	37	318	3.466E-12	346
LOKIASV2_0185_ESMFold_hypothetical_protein	7a1z-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7a1z-assembly1.cif.gz_A Crystal structure of human protein kinase CK2alpha' (CSNK2A2 gene product) in complex with the ATP-competitive inhibitor 6-bromo-5-chloro-1H-triazolo[4,5-b]pyridine	0.198	285	224	16	295	34	318	7.027E-12	346
LOKIASV2_0185_ESMFold_hypothetical_protein	4o0s-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4o0s-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	0.151	292	220	8	299	1	260	2.735E-11	345
LOKIASV2_0185_ESMFold_hypothetical_protein	3qd2-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3qd2-assembly1.cif.gz_B Crystal structure of mouse PERK kinase domain	0.189	274	208	16	289	8	265	1.278E-11	345
LOKIASV2_0185_ESMFold_hypothetical_protein	6qy8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6qy8-assembly1.cif.gz_A Human CSNK2A2 bound to ERB-041	0.195	283	225	16	295	33	315	3.660E-12	345
LOKIASV2_0185_ESMFold_hypothetical_protein	6l24-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6l24-assembly1.cif.gz_A Crystal structure of CK2a1 H115Y/V116I with hematein	0.185	296	237	16	307	38	333	1.303E-12	345
LOKIASV2_0185_ESMFold_hypothetical_protein	4mh7-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4mh7-assembly1.cif.gz_A Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1896	0.166	288	201	10	297	6	247	2.453E-11	344
LOKIASV2_0185_ESMFold_hypothetical_protein	4hjo-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4hjo-assembly1.cif.gz_A Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinib	0.160	299	228	10	308	5	276	1.028E-11	344
LOKIASV2_0185_ESMFold_hypothetical_protein	1oky-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1oky-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with staurosporine	0.172	266	196	16	281	11	248	2.590E-11	344
LOKIASV2_0185_ESMFold_hypothetical_protein	2wtk-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	2wtk-assembly2.cif.gz_C Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	0.176	274	208	16	289	3	256	1.278E-11	344
LOKIASV2_0185_ESMFold_hypothetical_protein	7aw2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7aw2-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor from a DNA-encoded library	0.184	281	202	16	296	20	267	1.974E-11	343
LOKIASV2_0185_ESMFold_hypothetical_protein	3g2f-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3g2f-assembly1.cif.gz_A Crystal structure of the kinase domain of bone morphogenetic protein receptor type II (BMPR2) at 2.35 A resolution	0.181	292	229	16	296	7	298	1.619E-12	343
LOKIASV2_0185_ESMFold_hypothetical_protein	4ra5-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4ra5-assembly1.cif.gz_B Human Protein Kinase C THETA IN COMPLEX WITH LIGAND COMPOUND 11a (6-[(1,3-Dimethyl-azetidin-3-yl)-methyl-amino]-4(R)-methyl-7-phenyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)	0.187	273	202	10	282	1	249	1.974E-11	343
LOKIASV2_0185_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D Human CSNK2A2 bound to ERB-041	0.186	283	227	16	295	33	315	7.419E-12	343
LOKIASV2_0185_ESMFold_hypothetical_protein	3orx-assembly5.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	3orx-assembly5.cif.gz_E PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	0.165	295	210	16	310	7	259	5.654E-12	342
LOKIASV2_0185_ESMFold_hypothetical_protein	4a4o-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	4a4o-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2-(2-AMINO- PYRIMIDIN-4-YL)-1,5,6,7-TETRAHYDRO-PYRROLOPYRIDIN-4-ONE INHIBITOR	0.182	285	210	14	298	13	270	2.323E-11	342
LOKIASV2_0185_ESMFold_hypothetical_protein	4eol-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4eol-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	0.193	285	228	16	298	7	291	4.549E-12	342
LOKIASV2_0185_ESMFold_hypothetical_protein	5h8g-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5h8g-assembly1.cif.gz_A Crystal structure of CK2 with compound 7b	0.185	284	228	16	296	37	320	7.834E-12	342
LOKIASV2_0185_ESMFold_hypothetical_protein	4dgl-assembly1.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4dgl-assembly1.cif.gz_D Crystal Structure of the CK2 Tetrameric Holoenzyme	0.176	285	230	16	295	37	321	5.071E-12	342
LOKIASV2_0185_ESMFold_hypothetical_protein	5n3b-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5n3b-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-(pyridin-3-yl)ethanamine	0.168	285	216	6	290	30	290	3.049E-11	342
LOKIASV2_0185_ESMFold_hypothetical_protein	5os5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5os5-assembly1.cif.gz_A Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment	0.154	291	220	8	298	2	262	5.544E-11	341
LOKIASV2_0185_ESMFold_hypothetical_protein	6bqq-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6bqq-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with BI2526	0.187	279	213	10	288	2	264	1.770E-11	341
LOKIASV2_0185_ESMFold_hypothetical_protein	3a7g-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3a7g-assembly2.cif.gz_B Human MST3 kinase	0.231	297	207	3	299	1	270	2.125E-12	341
LOKIASV2_0185_ESMFold_hypothetical_protein	6guc-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6guc-assembly1.cif.gz_A CDK2/CyclinA in complex with SU9516	0.193	283	225	16	298	5	284	1.677E-11	341
LOKIASV2_0185_ESMFold_hypothetical_protein	2pvl-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2pvl-assembly1.cif.gz_A Structure-Based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase CK2	0.179	291	233	16	300	34	324	2.789E-12	341
LOKIASV2_0185_ESMFold_hypothetical_protein	5li9-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5li9-assembly1.cif.gz_A Structure of a nucleotide-bound form of PKCiota core kinase domain	0.149	290	233	8	297	1	275	1.974E-11	341
LOKIASV2_0185_ESMFold_hypothetical_protein	2buj-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2buj-assembly2.cif.gz_B Crystal structure of the human Serine-threonine Kinase 16 in complex with staurosporine	0.189	291	225	4	294	4	282	1.677E-11	340
LOKIASV2_0185_ESMFold_hypothetical_protein	5uuu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5uuu-assembly1.cif.gz_A Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.153	288	235	10	297	75	353	9.221E-12	340
LOKIASV2_0185_ESMFold_hypothetical_protein	4yzb-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4yzb-assembly1.cif.gz_A CDPK1 from Eimeria tenella in complex with inhibitor UW1521	0.192	280	208	13	292	19	276	3.789E-11	340
LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly4.cif.gz_D Crystal structure of Nek7 SRS mutant bound to compound 51	0.202	282	196	16	297	12	257	1.323E-10	339
LOKIASV2_0185_ESMFold_hypothetical_protein	5z33-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5z33-assembly1.cif.gz_A Crystal structure of Mitogen-activated Protein Kinase Mps1 in Magnaporthe oryzae	0.193	319	241	5	304	1	319	2.013E-12	339
LOKIASV2_0185_ESMFold_hypothetical_protein	3tcp-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3tcp-assembly2.cif.gz_B Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC569	0.182	293	203	5	297	1	249	4.224E-11	338
LOKIASV2_0185_ESMFold_hypothetical_protein	4ct2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4ct2-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera	0.157	265	199	16	280	7	243	2.200E-11	338
LOKIASV2_0185_ESMFold_hypothetical_protein	6gih-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6gih-assembly1.cif.gz_A Crystal Structure of CK2alpha with CAM187 bound	0.193	285	228	16	298	37	321	8.733E-12	338
LOKIASV2_0185_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_A Crystal Structure of PKCiota kinase domain	0.151	290	237	8	297	2	281	4.710E-11	338
LOKIASV2_0185_ESMFold_hypothetical_protein	2biy-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2biy-assembly1.cif.gz_A Structure of PDK1-S241A mutant kinase domain	0.165	295	219	16	310	11	273	1.210E-11	337
LOKIASV2_0185_ESMFold_hypothetical_protein	5ts8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ts8-assembly1.cif.gz_A Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOTRIAZOLE	0.171	295	235	16	300	33	327	5.354E-12	337
LOKIASV2_0185_ESMFold_hypothetical_protein	1k9a-assembly7.cif.gz_D-2	LOKIASV2_0185_ESMFold_hypothetical_protein	1k9a-assembly7.cif.gz_D-2 Crystal structure analysis of full-length carboxyl-terminal Src kinase at 2.5 A resolution	0.181	290	207	10	299	178	431	5.071E-12	337
LOKIASV2_0185_ESMFold_hypothetical_protein	5lvp-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5lvp-assembly2.cif.gz_B Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.164	266	196	16	281	9	243	4.001E-11	336
LOKIASV2_0185_ESMFold_hypothetical_protein	4ct1-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4ct1-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera in Complex with Allosteric Compound PS315 Bound to the PIF-Pocket	0.161	295	220	16	310	7	269	1.210E-11	336
LOKIASV2_0185_ESMFold_hypothetical_protein	5am7-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5am7-assembly1.cif.gz_A FGFR1 mutant with an inhibitor	0.182	294	229	3	296	9	289	8.733E-12	336
LOKIASV2_0185_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MICROTUBULE AFFINITY-REGULATING KINASE 4 CATALYTIC DOMAIN IN COMPLEX WITH A PYRAZOLOPYRIMIDINE INHIBITOR	0.188	284	200	16	299	6	252	3.399E-11	336
LOKIASV2_0185_ESMFold_hypothetical_protein	3zh8-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	3zh8-assembly3.cif.gz_C A novel small molecule aPKC inhibitor	0.153	289	226	10	298	2	269	6.180E-11	336
LOKIASV2_0185_ESMFold_hypothetical_protein	5u6c-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5u6c-assembly1.cif.gz_B Crystal structure of the Mer kinase domain in complex with a macrocyclic inhibitor	0.172	281	200	16	296	13	254	1.869E-11	335
LOKIASV2_0185_ESMFold_hypothetical_protein	3h0z-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3h0z-assembly1.cif.gz_A Aurora A in complex with a bisanilinopyrimidine	0.145	284	205	16	299	6	246	4.973E-11	334
LOKIASV2_0185_ESMFold_hypothetical_protein	5os2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5os2-assembly1.cif.gz_A Crystal structure of Aurora-A kinase in complex with an allosterically binding fragment	0.159	283	209	16	298	7	256	8.111E-11	334
LOKIASV2_0185_ESMFold_hypothetical_protein	6s75-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6s75-assembly1.cif.gz_A Crystal structure of Nek7 bound to compound 51	0.163	282	208	16	297	16	265	1.397E-10	334
LOKIASV2_0185_ESMFold_hypothetical_protein	6unp-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6unp-assembly2.cif.gz_B Crystal structure of the kinase domain of BMPR2-D485G	0.191	291	227	16	297	7	297	7.834E-12	334
LOKIASV2_0185_ESMFold_hypothetical_protein	4d2w-assembly1.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4d2w-assembly1.cif.gz_D Structure of MELK in complex with inhibitors	0.178	286	206	16	301	11	262	1.210E-11	334
LOKIASV2_0185_ESMFold_hypothetical_protein	8cav-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8cav-assembly1.cif.gz_A Discovery of the lanthipeptide Curvocidin and structural insights into its trifunctional synthetase CuvL	0.168	297	223	1	297	196	464	3.864E-12	334
LOKIASV2_0185_ESMFold_hypothetical_protein	2h34-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2h34-assembly2.cif.gz_B Apoenzyme crystal structure of the tuberculosis serine/threonine kinase, PknE	0.214	277	185	16	292	3	239	2.682E-10	333
LOKIASV2_0185_ESMFold_hypothetical_protein	2c6e-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2c6e-assembly1.cif.gz_A Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	0.155	283	204	16	298	7	248	4.710E-11	333
LOKIASV2_0185_ESMFold_hypothetical_protein	5zan-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5zan-assembly1.cif.gz_A Crystal Structure of Aurora-A in complex with a new Quinazoline inhibitor	0.154	283	210	16	298	7	255	4.710E-11	333
LOKIASV2_0185_ESMFold_hypothetical_protein	5drd-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5drd-assembly1.cif.gz_A Aurora A Kinase in Complex with ATP in Space Group P6122	0.151	284	211	16	299	7	255	3.789E-11	333
LOKIASV2_0185_ESMFold_hypothetical_protein	8ej4-assembly1.cif.gz_K	LOKIASV2_0185_ESMFold_hypothetical_protein	8ej4-assembly1.cif.gz_K Cryo-EM structure of the active NLRP3 inflammasome disk	0.167	280	204	16	295	15	260	1.253E-10	333
LOKIASV2_0185_ESMFold_hypothetical_protein	5u6b-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	5u6b-assembly3.cif.gz_C Structure of the Axl kinase domain in complex with a macrocyclic inhibitor	0.184	282	204	16	297	16	266	3.049E-11	333
LOKIASV2_0185_ESMFold_hypothetical_protein	3aox-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3aox-assembly1.cif.gz_A X-ray crystal structure of human anaplastic lymphoma kinase in complex with CH5424802	0.151	297	240	7	303	8	291	7.027E-12	333
LOKIASV2_0185_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A Inhibitory scaffolding of the ancient MAPK, ERK7	0.186	279	225	16	294	10	286	1.048E-12	333
LOKIASV2_0185_ESMFold_hypothetical_protein	2vo0-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2vo0-assembly1.cif.gz_A Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-yl)methylamine	0.170	289	217	10	298	31	292	1.424E-11	333
LOKIASV2_0185_ESMFold_hypothetical_protein	8ahi-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8ahi-assembly1.cif.gz_A PAC-FragmentDEL: Photoactivated covalent capture of DNA encoded fragments for hit discovery	0.187	293	211	5	297	14	274	4.710E-11	332
LOKIASV2_0185_ESMFold_hypothetical_protein	4btj-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4btj-assembly2.cif.gz_B TTBK1 in complex with ATP	0.142	297	238	4	300	4	281	1.397E-10	332
LOKIASV2_0185_ESMFold_hypothetical_protein	5f9e-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5f9e-assembly2.cif.gz_B Structure of Protein Kinase C theta with compound 10: 2,2-dimethyl-7-(2-oxidanylidene-3~{H}-imidazo[4,5-b]pyridin-1-yl)-1-(phenylmethyl)-3~{H}-quinazolin-4-one	0.168	288	225	10	297	1	271	8.111E-11	332
LOKIASV2_0185_ESMFold_hypothetical_protein	8pqc-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	8pqc-assembly2.cif.gz_B c-KIT kinase domain in complex with avapritinib derivative 9	0.185	296	231	3	298	12	295	3.399E-11	332
LOKIASV2_0185_ESMFold_hypothetical_protein	3ocb-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3ocb-assembly1.cif.gz_A Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.147	289	226	9	297	1	266	5.853E-11	332
LOKIASV2_0185_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A Crystal structure of CX-4945 bound CK2 alpha from C. neoformans	0.171	290	233	16	297	33	322	6.655E-12	332
LOKIASV2_0185_ESMFold_hypothetical_protein	5ouu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ouu-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 22	0.178	285	232	16	298	38	322	1.278E-11	332
LOKIASV2_0185_ESMFold_hypothetical_protein	1na7-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1na7-assembly1.cif.gz_A Crystal structure of the catalytic subunit of human protein kinase CK2	0.196	288	227	16	298	36	323	7.834E-12	332
LOKIASV2_0185_ESMFold_hypothetical_protein	3h10-assembly3.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	3h10-assembly3.cif.gz_D Aurora A inhibitor complex	0.158	291	212	8	298	1	253	4.710E-11	330
LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_B Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.166	277	206	16	292	11	258	3.923E-10	330
LOKIASV2_0185_ESMFold_hypothetical_protein	5a6n-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5a6n-assembly1.cif.gz_A Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with compound 2	0.196	285	214	13	297	4	270	1.424E-11	330
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_A Structure of RIP2K(D146N) with bound Staurosporine	0.148	288	219	9	296	14	271	6.180E-11	330
LOKIASV2_0185_ESMFold_hypothetical_protein	8stg-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8stg-assembly1.cif.gz_A Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations	0.187	283	208	16	298	21	277	2.590E-11	330
LOKIASV2_0185_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A The crystal structure of MPK38 in complex with OTSSP167, an orally- administrative MELK selective inhibitor	0.184	286	195	16	301	10	249	2.323E-11	330
LOKIASV2_0185_ESMFold_hypothetical_protein	6kyq-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6kyq-assembly2.cif.gz_B Crystal structure of DCLK1 Autoinhibited Kinase Domain	0.218	285	201	16	300	11	268	1.974E-11	330
LOKIASV2_0185_ESMFold_hypothetical_protein	6t6f-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6t6f-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase 1D (CAMK1D) bound to compound 8 (CS275)	0.166	296	227	16	311	12	284	1.424E-11	329
LOKIASV2_0185_ESMFold_hypothetical_protein	4twc-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4twc-assembly2.cif.gz_B 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of CK1d/e	0.155	290	232	8	297	1	276	8.111E-11	329
LOKIASV2_0185_ESMFold_hypothetical_protein	6bku-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6bku-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B bound to GSK650394	0.181	279	211	10	288	2	260	5.853E-11	328
LOKIASV2_0185_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5uor-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	0.172	273	199	16	288	3	243	1.935E-10	327
LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_E Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.155	275	199	16	290	15	250	4.876E-10	327
LOKIASV2_0185_ESMFold_hypothetical_protein	4jbq-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4jbq-assembly1.cif.gz_A Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules	0.148	291	214	8	298	1	252	1.475E-10	327
LOKIASV2_0185_ESMFold_hypothetical_protein	1how-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1how-assembly1.cif.gz_A THE X-RAY CRYSTAL STRUCTURE OF SKY1P, AN SR PROTEIN KINASE IN YEAST	0.172	321	249	4	305	4	324	7.027E-12	327
LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly3.cif.gz_C Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.158	289	232	6	294	148	423	9.736E-12	327
LOKIASV2_0185_ESMFold_hypothetical_protein	5dpv-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5dpv-assembly1.cif.gz_A Aurora A Kinase in Complex with AA35 and JNJ-7706621 in Space Group P6122	0.147	283	211	16	298	7	254	1.008E-10	326
LOKIASV2_0185_ESMFold_hypothetical_protein	3g5d-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3g5d-assembly2.cif.gz_B Kinase domain of cSrc in complex with Dasatinib	0.164	285	200	16	300	10	249	8.564E-11	326
LOKIASV2_0185_ESMFold_hypothetical_protein	6bqp-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6bqp-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with Crenolanib	0.180	279	209	10	288	1	256	6.180E-11	326
LOKIASV2_0185_ESMFold_hypothetical_protein	3dbe-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3dbe-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 557	0.157	291	223	2	292	1	266	2.043E-10	326
LOKIASV2_0185_ESMFold_hypothetical_protein	7nzy-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	7nzy-assembly4.cif.gz_D Crystal structure of human Casein Kinase I delta in complex with CGS-15943	0.162	293	232	10	302	1	278	7.275E-11	326
LOKIASV2_0185_ESMFold_hypothetical_protein	2cjm-assembly2.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2cjm-assembly2.cif.gz_A Mechanism of CDK inhibition by active site phosphorylation: CDK2 Y15p T160p in complex with cyclin A structure	0.186	283	227	16	298	4	283	4.710E-11	326
LOKIASV2_0185_ESMFold_hypothetical_protein	4ks8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4ks8-assembly1.cif.gz_A PAK6 kinase domain in complex with sunitinib	0.176	287	214	16	302	23	283	5.251E-11	326
LOKIASV2_0185_ESMFold_hypothetical_protein	6kyr-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6kyr-assembly2.cif.gz_B Crystal structure of DCLK1 mutant (P675L) Autoinhibited Kinase Domain	0.214	285	203	16	300	11	269	2.200E-11	326
LOKIASV2_0185_ESMFold_hypothetical_protein	4ekk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4ekk-assembly1.cif.gz_A Akt1 with AMP-PNP	0.147	290	227	9	298	1	267	1.833E-10	326
LOKIASV2_0185_ESMFold_hypothetical_protein	3w8l-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3w8l-assembly2.cif.gz_B Crystal structure of human CK2 in complex with inositol hexakisphosphate	0.194	285	225	16	295	36	320	1.869E-11	326
LOKIASV2_0185_ESMFold_hypothetical_protein	7psu-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7psu-assembly2.cif.gz_B Structure of protein kinase CK2alpha mutant K198R associated with the Okur-Chung Neurodevelopmental Syndrome	0.195	286	225	16	296	38	323	1.278E-11	326
LOKIASV2_0185_ESMFold_hypothetical_protein	1apm-assembly1.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	1apm-assembly1.cif.gz_E 2.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT	0.160	279	213	10	288	29	283	7.275E-11	326
LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly2.cif.gz_B Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.158	289	232	6	294	149	424	9.736E-12	326
LOKIASV2_0185_ESMFold_hypothetical_protein	6s75-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6s75-assembly3.cif.gz_C Crystal structure of Nek7 bound to compound 51	0.164	282	207	16	297	13	261	2.990E-10	325
LOKIASV2_0185_ESMFold_hypothetical_protein	5lqf-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5lqf-assembly1.cif.gz_A CDK1/CyclinB1/CKS2 in complex with NU6102	0.165	283	234	16	298	7	287	2.590E-11	325
LOKIASV2_0185_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8	LOKIASV2_0185_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8 TFIID-based holo PIC on SCP promoter	0.209	288	225	14	301	2	286	1.770E-11	325
LOKIASV2_0185_ESMFold_hypothetical_protein	3ocb-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3ocb-assembly2.cif.gz_B Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.147	289	226	9	297	1	266	1.253E-10	325
LOKIASV2_0185_ESMFold_hypothetical_protein	2jed-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2jed-assembly2.cif.gz_B The crystal structure of the kinase domain of the protein kinase C theta in complex with NVP-XAA228 at 2.32A resolution.	0.186	288	220	10	297	1	271	7.682E-11	325
LOKIASV2_0185_ESMFold_hypothetical_protein	3l9m-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3l9m-assembly2.cif.gz_B Crystal structure of PKAB3 (pka triple mutant V123A, L173M, Q181K) with compound 18	0.163	283	214	16	298	31	287	4.973E-11	325
LOKIASV2_0185_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_A Crystal Structure of PF11_0147	0.199	310	231	10	299	11	320	5.969E-12	325
LOKIASV2_0185_ESMFold_hypothetical_protein	5k0k-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5k0k-assembly2.cif.gz_B Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC2434	0.172	283	195	16	298	11	247	5.544E-11	324
LOKIASV2_0185_ESMFold_hypothetical_protein	6yid-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6yid-assembly2.cif.gz_C Crystal structure of ULK2 in complex with SBI-0206965	0.165	282	210	7	288	2	253	7.275E-11	324
LOKIASV2_0185_ESMFold_hypothetical_protein	7olx-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7olx-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor containing a tri-methyl pyrazole group	0.189	281	204	16	296	21	272	3.789E-11	324
LOKIASV2_0185_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	0.188	292	211	5	296	15	275	1.677E-11	324
LOKIASV2_0185_ESMFold_hypothetical_protein	4fob-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4fob-assembly1.cif.gz_A Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 1	0.153	289	236	8	296	2	281	1.349E-11	324
LOKIASV2_0185_ESMFold_hypothetical_protein	4q9z-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4q9z-assembly1.cif.gz_B Human Protein Kinase C Theta in Complex with Compound35 ((1R)-9-(AZETIDIN-3-YLAMINO)-1,8-DIMETHYL-3,5-DIHYDRO[1,2,4]TRIAZINO[3,4-C][1,4]BENZOXAZIN-2(1H)-ONE)	0.180	288	221	10	297	2	272	1.187E-10	324
LOKIASV2_0185_ESMFold_hypothetical_protein	6npz-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6npz-assembly1.cif.gz_A Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate	0.140	291	230	8	298	2	269	9.547E-11	324
LOKIASV2_0185_ESMFold_hypothetical_protein	5uvc-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5uvc-assembly1.cif.gz_A Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.159	288	234	10	297	130	408	2.453E-11	324
LOKIASV2_0185_ESMFold_hypothetical_protein	4mha-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4mha-assembly2.cif.gz_B Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1817	0.168	283	195	16	298	11	245	1.124E-10	323
LOKIASV2_0185_ESMFold_hypothetical_protein	8edh-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	8edh-assembly2.cif.gz_C Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	0.186	280	201	16	295	11	258	2.735E-11	323
LOKIASV2_0185_ESMFold_hypothetical_protein	3ue4-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3ue4-assembly2.cif.gz_B Structural and spectroscopic analysis of the kinase inhibitor bosutinib binding to the Abl tyrosine kinase domain	0.193	282	206	16	297	10	265	1.064E-10	323
LOKIASV2_0185_ESMFold_hypothetical_protein	4f1o-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4f1o-assembly1.cif.gz_A Crystal Structure of the L1180T mutant Roco4 Kinase Domain from D. discoideum bound to AppCp	0.187	278	215	16	293	10	275	5.544E-11	323
LOKIASV2_0185_ESMFold_hypothetical_protein	3d5x-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3d5x-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with wortmannin.	0.160	297	221	2	298	1	264	1.557E-10	323
LOKIASV2_0185_ESMFold_hypothetical_protein	6hmr-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6hmr-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with a photoswitchable 2-Azothiazole-based inhibitor (compound 2)	0.163	288	219	10	297	4	266	1.475E-10	323
LOKIASV2_0185_ESMFold_hypothetical_protein	7p7f-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	7p7f-assembly3.cif.gz_C Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 1	0.147	285	227	13	297	4	270	1.064E-10	323
LOKIASV2_0185_ESMFold_hypothetical_protein	3zh8-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3zh8-assembly2.cif.gz_B A novel small molecule aPKC inhibitor	0.153	289	226	10	298	2	269	1.935E-10	323
LOKIASV2_0185_ESMFold_hypothetical_protein	4md9-assembly1.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	4md9-assembly1.cif.gz_E Crystal Structure of symmetric CK2 holoenzyme with mutated alpha subunit (F121E truncated at aa 336)	0.196	285	224	16	295	38	322	1.210E-11	323
LOKIASV2_0185_ESMFold_hypothetical_protein	6b1u-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6b1u-assembly2.cif.gz_C Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	0.187	303	228	8	310	1	282	1.974E-11	323
LOKIASV2_0185_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A Structure of Human YSK1 (Yeast Sps1-Ste20-related Kinase 1)	0.210	282	198	16	297	18	268	1.588E-11	322
LOKIASV2_0185_ESMFold_hypothetical_protein	1j1b-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	1j1b-assembly1.cif.gz_B Binary complex structure of human tau protein kinase I with AMPPNP	0.163	290	234	14	294	32	321	5.544E-11	322
LOKIASV2_0185_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_C ASK1 kinase domain in complex with GS-4997	0.178	273	187	16	288	3	231	1.323E-10	321
LOKIASV2_0185_ESMFold_hypothetical_protein	5odt-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5odt-assembly1.cif.gz_A Aurora-A in complex with TACC3	0.151	291	213	8	298	1	252	6.180E-11	321
LOKIASV2_0185_ESMFold_hypothetical_protein	6bql-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6bql-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with TAE-226	0.178	279	221	10	288	2	271	2.453E-11	321
LOKIASV2_0185_ESMFold_hypothetical_protein	1xh9-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1xh9-assembly1.cif.gz_A Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mutants	0.164	281	214	10	290	26	282	9.042E-11	321
LOKIASV2_0185_ESMFold_hypothetical_protein	5o7i-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5o7i-assembly1.cif.gz_A ERK5 in complex with a pyrrole inhibitor	0.178	303	238	16	306	2	304	9.736E-12	321
LOKIASV2_0185_ESMFold_hypothetical_protein	7oam-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7oam-assembly2.cif.gz_B Kinase domain of MERTK in complex with compound 8	0.188	291	193	16	306	12	250	1.253E-10	320
LOKIASV2_0185_ESMFold_hypothetical_protein	7nzy-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	7nzy-assembly3.cif.gz_C Crystal structure of human Casein Kinase I delta in complex with CGS-15943	0.161	299	231	4	302	1	276	2.158E-10	320
LOKIASV2_0185_ESMFold_hypothetical_protein	6cmj-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6cmj-assembly2.cif.gz_B Human CAMKK2 with GSK650393	0.169	285	231	16	300	5	283	1.124E-10	320
LOKIASV2_0185_ESMFold_hypothetical_protein	7jxy-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7jxy-assembly2.cif.gz_B Structure of TTBK1 kinase domain in complex with Compound 18	0.143	300	237	1	300	1	277	1.124E-10	320
LOKIASV2_0185_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A Crystal structure of PF14_0431, kinase domain.	0.165	334	245	3	296	7	340	2.200E-11	320
LOKIASV2_0185_ESMFold_hypothetical_protein	6gra-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6gra-assembly1.cif.gz_A Human AURKA bound to BRD-7880	0.143	291	211	8	298	1	247	1.397E-10	319
LOKIASV2_0185_ESMFold_hypothetical_protein	5k0x-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5k0x-assembly2.cif.gz_B Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC2541	0.179	278	195	20	297	14	251	6.180E-11	319
LOKIASV2_0185_ESMFold_hypothetical_protein	6s75-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6s75-assembly2.cif.gz_B Crystal structure of Nek7 bound to compound 51	0.171	282	207	16	297	15	265	3.716E-10	319
LOKIASV2_0185_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_F	LOKIASV2_0185_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_F Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	0.164	289	210	11	299	1	252	2.158E-10	319
LOKIASV2_0185_ESMFold_hypothetical_protein	5o0y-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5o0y-assembly1.cif.gz_A TLK2 kinase domain from human	0.182	283	230	13	295	5	286	3.049E-11	319
LOKIASV2_0185_ESMFold_hypothetical_protein	1yhw-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1yhw-assembly1.cif.gz_A Crystal Structure of PAK1 kinase domain with one point mutations (K299R)	0.173	277	208	16	292	22	274	3.219E-11	319
LOKIASV2_0185_ESMFold_hypothetical_protein	6rcg-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6rcg-assembly1.cif.gz_A Crystal structure of Casein kinase 1 delta (CK1 delta) complexed with SR3029 inhibitor	0.163	297	234	1	297	2	281	1.397E-10	319
LOKIASV2_0185_ESMFold_hypothetical_protein	2xmy-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2xmy-assembly1.cif.gz_A Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents	0.163	283	235	16	298	4	285	3.219E-11	319
LOKIASV2_0185_ESMFold_hypothetical_protein	6fd3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6fd3-assembly1.cif.gz_A Thiophosphorylated PAK3 kinase domain	0.173	284	209	13	296	22	275	8.271E-12	319
LOKIASV2_0185_ESMFold_hypothetical_protein	6kmh-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6kmh-assembly2.cif.gz_B The crystal structure of CASK/Mint1 complex	0.195	285	216	16	300	8	276	1.187E-10	319
LOKIASV2_0185_ESMFold_hypothetical_protein	4kb8-assembly5.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4kb8-assembly5.cif.gz_A CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand	0.144	288	214	10	297	1	251	1.736E-10	318
LOKIASV2_0185_ESMFold_hypothetical_protein	8qlq-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8qlq-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with macrocyclic inhibitor JA310	0.224	285	206	16	300	10	276	7.834E-12	318
LOKIASV2_0185_ESMFold_hypothetical_protein	5okt-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5okt-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with IWP-2	0.147	285	224	13	297	4	267	2.158E-10	318
LOKIASV2_0185_ESMFold_hypothetical_protein	7p7g-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7p7g-assembly2.cif.gz_B Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 2 and 3	0.152	282	227	16	297	3	271	9.042E-11	318
LOKIASV2_0185_ESMFold_hypothetical_protein	6t2w-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6t2w-assembly1.cif.gz_A Crystal structure of the CSF1R kinase domain with a dihydropurinone inhibitor (compound 4)	0.196	281	216	16	296	34	303	8.111E-11	318
LOKIASV2_0185_ESMFold_hypothetical_protein	5xvu-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	5xvu-assembly3.cif.gz_C Crystal structure of the protein kinase CK2 catalytic domain from Plasmodium falciparum bound to ATP	0.188	293	231	10	295	24	316	1.974E-11	318
LOKIASV2_0185_ESMFold_hypothetical_protein	4dc2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4dc2-assembly1.cif.gz_A Structure of PKC in Complex with a Substrate Peptide from Par-3	0.152	288	232	10	297	1	275	1.644E-10	318
LOKIASV2_0185_ESMFold_hypothetical_protein	5n1m-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5n1m-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule (5-chloro-2-methoxyphenyl)methanamine	0.174	279	210	10	288	39	293	1.124E-10	318
LOKIASV2_0185_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_B Crystal Structure of PF11_0147	0.183	306	235	10	298	6	311	2.323E-11	318
LOKIASV2_0185_ESMFold_hypothetical_protein	3igo-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3igo-assembly1.cif.gz_A Crystal structure of Cryptosporidium parvum CDPK1, cgd3_920	0.190	282	205	13	294	6	259	5.544E-11	318
LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly2.cif.gz_C CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.189	287	209	13	299	5	263	3.589E-11	318
LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly1.cif.gz_A Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.157	289	232	6	294	151	426	7.834E-12	318
LOKIASV2_0185_ESMFold_hypothetical_protein	3d2k-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3d2k-assembly1.cif.gz_A Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with [7-(2-{2-[3-(3-chloro-phenyl)-ureido]-thiazol-5-yl}-ethylamino)-pyrazolo[4,3-d]pyrimidin-1-yl]-acetic acid	0.155	289	204	10	298	1	243	5.149E-10	317
LOKIASV2_0185_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3fdn-assembly1.cif.gz_A Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity	0.151	291	214	8	298	1	253	2.158E-10	317
LOKIASV2_0185_ESMFold_hypothetical_protein	4tw9-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4tw9-assembly1.cif.gz_B Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation	0.156	290	230	8	297	1	273	3.333E-10	317
LOKIASV2_0185_ESMFold_hypothetical_protein	3zo4-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3zo4-assembly1.cif.gz_A The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors	0.173	279	210	10	288	25	279	5.251E-11	317
LOKIASV2_0185_ESMFold_hypothetical_protein	2gnf-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2gnf-assembly1.cif.gz_A Protein kinase A fivefold mutant model of Rho-kinase with Y-27632	0.163	291	227	10	300	29	300	3.049E-11	317
LOKIASV2_0185_ESMFold_hypothetical_protein	3pfq-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3pfq-assembly1.cif.gz_A Crystal Structure and Allosteric Activation of Protein Kinase C beta II	0.184	265	197	16	280	196	437	2.540E-10	317
LOKIASV2_0185_ESMFold_hypothetical_protein	4kba-assembly5.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4kba-assembly5.cif.gz_A CK1d in complex with 9-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]-2,3,4,5-tetrahydropyrido[2,3-f][1,4]oxazepine inhibitor	0.154	288	210	10	297	1	249	1.702E-09	316
LOKIASV2_0185_ESMFold_hypothetical_protein	5cvf-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5cvf-assembly1.cif.gz_A Crystal Structure of CK2alpha with Compound 5 bound	0.193	286	228	16	298	37	322	3.789E-11	316
LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4wbo-assembly4.cif.gz_D Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	0.156	289	232	6	294	144	419	8.271E-12	316
LOKIASV2_0185_ESMFold_hypothetical_protein	6ccf-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6ccf-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with Hesperadin	0.190	279	204	10	288	1	253	3.049E-11	315
LOKIASV2_0185_ESMFold_hypothetical_protein	8stg-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	8stg-assembly2.cif.gz_B Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations	0.182	281	213	16	296	10	271	1.187E-10	315
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5ng2-assembly1.cif.gz_B Structure of RIP2K(D146N) with bound Staurosporine	0.153	288	221	9	296	14	275	2.540E-10	315
LOKIASV2_0185_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	0.165	285	224	16	300	17	285	8.733E-12	315
LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_A Crystal structure of the kinase domain of CIPK23	0.219	292	210	3	294	1	270	3.049E-11	315
LOKIASV2_0185_ESMFold_hypothetical_protein	5otl-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5otl-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 29	0.183	281	228	16	295	36	316	7.275E-11	315
LOKIASV2_0185_ESMFold_hypothetical_protein	5clp-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5clp-assembly1.cif.gz_A Crystal Structure of CK2alpha with 3,4-dichlorophenethylamine bound	0.192	280	225	16	295	37	316	5.544E-11	315
LOKIASV2_0185_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_B Crystal Structure of PKCiota kinase domain	0.159	303	234	8	310	3	281	8.111E-11	315
LOKIASV2_0185_ESMFold_hypothetical_protein	1q97-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1q97-assembly1.cif.gz_A The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	0.165	326	251	4	305	4	329	2.888E-11	315
LOKIASV2_0185_ESMFold_hypothetical_protein	2jd5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2jd5-assembly1.cif.gz_A Sky1p bound to Npl3p-derived substrate peptide	0.162	330	259	1	310	1	330	4.973E-11	315
LOKIASV2_0185_ESMFold_hypothetical_protein	6qat-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6qat-assembly2.cif.gz_C Crystal structure of ULK2 in complexed with hesperadin	0.175	285	210	8	292	1	256	3.923E-10	314
LOKIASV2_0185_ESMFold_hypothetical_protein	5de2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5de2-assembly1.cif.gz_A Structural mechanism of Nek7 activation by Nek9-induced dimerisation	0.189	282	203	16	297	15	265	7.953E-10	314
LOKIASV2_0185_ESMFold_hypothetical_protein	7z5n-assembly8.cif.gz_H	LOKIASV2_0185_ESMFold_hypothetical_protein	7z5n-assembly8.cif.gz_H Crystal structure of DYRK1A in complex with CX-4945	0.164	289	239	3	289	14	302	2.158E-10	314
LOKIASV2_0185_ESMFold_hypothetical_protein	5vhb-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5vhb-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitor	0.164	299	232	10	308	21	298	1.770E-11	314
LOKIASV2_0185_ESMFold_hypothetical_protein	4qpm-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4qpm-assembly2.cif.gz_B Structure of Bub1 kinase domain	0.164	298	231	1	298	33	309	5.853E-11	314
LOKIASV2_0185_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A Crystal structure of non-phosphorylated Fus3	0.169	286	236	16	300	13	298	4.710E-11	314
LOKIASV2_0185_ESMFold_hypothetical_protein	4fr4-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4fr4-assembly3.cif.gz_C Crystal structure of human serine/threonine-protein kinase 32A (YANK1)	0.163	287	223	8	294	3	269	3.789E-11	314
LOKIASV2_0185_ESMFold_hypothetical_protein	1q99-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1q99-assembly1.cif.gz_A Crystal structure of the Saccharomyces cerevisiae SR protein kinsae, Sky1p, complexed with the non-hydrolyzable ATP analogue, AMP-PNP	0.165	329	252	3	305	4	332	1.504E-11	314
LOKIASV2_0185_ESMFold_hypothetical_protein	6cd6-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6cd6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.183	273	207	16	288	4	257	1.008E-10	313
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_A Structure of RIP2K(L294F) with bound AMPPCP	0.151	288	217	9	296	13	269	3.157E-10	313
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_B Structure of RIP2K(L294F) with bound AMPPCP	0.143	288	226	9	296	14	278	3.519E-10	313
LOKIASV2_0185_ESMFold_hypothetical_protein	4d2p-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4d2p-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	0.181	286	206	16	301	11	262	3.399E-11	313
LOKIASV2_0185_ESMFold_hypothetical_protein	3ag9-assembly3.cif.gz_B-2	LOKIASV2_0185_ESMFold_hypothetical_protein	3ag9-assembly3.cif.gz_B-2 Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1012	0.172	279	210	10	288	24	278	8.111E-11	313
LOKIASV2_0185_ESMFold_hypothetical_protein	6buu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6buu-assembly1.cif.gz_A Crystal structure of AKT1 (aa 144-480) with a bisubstrate	0.153	290	225	9	298	1	267	2.540E-10	313
LOKIASV2_0185_ESMFold_hypothetical_protein	4mq1-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4mq1-assembly4.cif.gz_D The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.147	320	244	3	289	14	333	8.564E-11	313
LOKIASV2_0185_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	0.207	263	189	3	265	1	239	2.682E-10	313
LOKIASV2_0185_ESMFold_hypothetical_protein	5ezr-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ezr-assembly1.cif.gz_A Crystal Structure of PVX_084705 bound to compound	0.160	293	225	6	298	513	781	9.547E-11	313
LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6s73-assembly2.cif.gz_B Crystal structure of Nek7 SRS mutant bound to compound 51	0.183	282	205	16	297	15	266	4.618E-10	312
LOKIASV2_0185_ESMFold_hypothetical_protein	3uyt-assembly5.cif.gz_D-2	LOKIASV2_0185_ESMFold_hypothetical_protein	3uyt-assembly5.cif.gz_D-2 crystal structure of ck1d with PF670462 from P1 crystal form	0.142	285	214	13	297	4	253	2.278E-10	312
LOKIASV2_0185_ESMFold_hypothetical_protein	4yzn-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4yzn-assembly1.cif.gz_A Humanized Roco4 bound to Compound 19	0.186	284	216	10	293	3	268	1.064E-10	312
LOKIASV2_0185_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_A Crystal Structure of PKCiota kinase domain	0.149	303	235	8	310	2	278	4.460E-11	312
LOKIASV2_0185_ESMFold_hypothetical_protein	6eiq-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6eiq-assembly3.cif.gz_C DYRK1A in complex with XMD14-124	0.151	319	248	3	295	14	332	4.460E-11	312
LOKIASV2_0185_ESMFold_hypothetical_protein	5n3d-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5n3d-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 4-(trifluoromethyl)benzenecarboximidamide	0.174	279	210	10	288	38	292	2.278E-10	312
LOKIASV2_0185_ESMFold_hypothetical_protein	6eh3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6eh3-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp190	0.164	279	212	10	288	41	295	2.043E-10	312
LOKIASV2_0185_ESMFold_hypothetical_protein	4z84-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4z84-assembly1.cif.gz_A PKAB3 in complex with pyrrolidine inhibitor 34a	0.165	279	212	10	288	25	279	2.278E-10	311
LOKIASV2_0185_ESMFold_hypothetical_protein	5n1o-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5n1o-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-chloro-4-(chloromethyl)-5-hydroxyphenyl)ethan-1-one	0.175	279	210	10	288	28	282	2.278E-10	311
LOKIASV2_0185_ESMFold_hypothetical_protein	1xha-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1xha-assembly1.cif.gz_A Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mutants	0.170	281	212	10	290	38	294	6.526E-11	311
LOKIASV2_0185_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_D-3	LOKIASV2_0185_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_D-3 ASK1 kinase domain in complex with Compound 11	0.174	272	201	17	288	11	254	2.158E-10	310
LOKIASV2_0185_ESMFold_hypothetical_protein	5vib-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5vib-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitors	0.156	299	234	10	308	21	298	1.008E-10	310
LOKIASV2_0185_ESMFold_hypothetical_protein	5a3x-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	5a3x-assembly3.cif.gz_C DYRK1A in complex with hydroxy benzothiazole fragment	0.155	317	247	3	295	15	331	7.275E-11	310
LOKIASV2_0185_ESMFold_hypothetical_protein	4jrn-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4jrn-assembly1.cif.gz_A ROP18 kinase domain in complex with AMP-PNP and sucrose	0.163	292	243	14	304	57	348	1.869E-11	310
LOKIASV2_0185_ESMFold_hypothetical_protein	7pie-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7pie-assembly1.cif.gz_A Protein kinase A catalytic subunit in complex with PKI5-24 and EN068	0.163	274	205	8	281	39	284	2.158E-10	310
LOKIASV2_0185_ESMFold_hypothetical_protein	6c83-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6c83-assembly1.cif.gz_B Structure of Aurora A (122-403) bound to inhibitory Monobody Mb2 and AMPPCP	0.152	283	202	16	298	7	245	2.405E-10	309
LOKIASV2_0185_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	6oyw-assembly1.cif.gz_A-2 ASK1 kinase domain in complex with Compound 11	0.172	273	209	16	288	3	255	3.923E-10	309
LOKIASV2_0185_ESMFold_hypothetical_protein	5cs6-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5cs6-assembly2.cif.gz_B Crystal Structure of CK2alpha with Compound 3 bound	0.190	283	226	16	298	36	315	8.564E-11	309
LOKIASV2_0185_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3a8w-assembly3.cif.gz_B Crystal Structure of PKCiota kinase domain	0.151	303	235	8	310	2	279	1.644E-10	309
LOKIASV2_0185_ESMFold_hypothetical_protein	4wb6-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4wb6-assembly1.cif.gz_A Crystal structure of a L205R mutant of human cAMP-dependent protein kinase A (catalytic alpha subunit)	0.171	279	211	10	288	26	280	1.008E-10	309
LOKIASV2_0185_ESMFold_hypothetical_protein	5bx7-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5bx7-assembly1.cif.gz_A PKA in complex with a benzothiophene fragment compound.	0.162	289	220	10	298	34	296	1.253E-10	309
LOKIASV2_0185_ESMFold_hypothetical_protein	3qam-assembly1.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	3qam-assembly1.cif.gz_E Crystal Structure of Glu208Ala mutant of catalytic subunit of cAMP-dependent protein kinase	0.159	291	223	10	300	38	303	4.001E-11	309
LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly3.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly3.cif.gz_E CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.196	290	211	10	299	2	264	6.526E-11	309
LOKIASV2_0185_ESMFold_hypothetical_protein	4uzh-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4uzh-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.141	291	209	8	298	3	246	3.716E-10	308
LOKIASV2_0185_ESMFold_hypothetical_protein	2wma-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	2wma-assembly2.cif.gz_C Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin A	0.195	283	204	16	298	5	258	6.060E-10	308
LOKIASV2_0185_ESMFold_hypothetical_protein	6cd6-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6cd6-assembly4.cif.gz_D Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.186	283	216	10	292	1	266	8.564E-11	308
LOKIASV2_0185_ESMFold_hypothetical_protein	7xhy-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7xhy-assembly1.cif.gz_A Crystal structure of MerTK Kinase domain with BMS794833	0.190	291	203	16	306	20	270	5.251E-11	308
LOKIASV2_0185_ESMFold_hypothetical_protein	8bok-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8bok-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 11	0.186	297	217	1	297	1	267	1.323E-10	308
LOKIASV2_0185_ESMFold_hypothetical_protein	5okt-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5okt-assembly1.cif.gz_A Crystal structure of human Casein Kinase I delta in complex with IWP-2	0.147	285	228	13	297	4	271	4.618E-10	308
LOKIASV2_0185_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B Crystal structure of Casein kinase I homolog 1	0.190	282	220	16	297	8	280	3.399E-11	308
LOKIASV2_0185_ESMFold_hypothetical_protein	5x27-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5x27-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 L858R in complex with SKLB(5)	0.158	286	216	16	301	16	273	1.064E-10	308
LOKIASV2_0185_ESMFold_hypothetical_protein	1zrz-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1zrz-assembly1.cif.gz_A Crystal Structure of the Catalytic Domain of Atypical Protein Kinase C-iota	0.170	272	205	10	281	1	248	4.374E-10	308
LOKIASV2_0185_ESMFold_hypothetical_protein	5w91-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5w91-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor LZH118	0.201	287	209	13	299	7	269	8.111E-11	308
LOKIASV2_0185_ESMFold_hypothetical_protein	4uzd-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4uzd-assembly2.cif.gz_B SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.145	291	216	8	298	2	255	1.064E-10	307
LOKIASV2_0185_ESMFold_hypothetical_protein	5k0k-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5k0k-assembly1.cif.gz_A Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC2434	0.178	282	202	16	297	11	257	1.008E-10	307
LOKIASV2_0185_ESMFold_hypothetical_protein	7ako-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7ako-assembly1.cif.gz_A Crystal structure of CHK1 kinase domain in complex with a CLASPIN phosphopeptide	0.197	275	203	16	290	8	261	5.436E-10	307
LOKIASV2_0185_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2qnj-assembly1.cif.gz_A Kinase and Ubiquitin-associated domains of MARK3/Par-1	0.160	284	213	16	299	13	266	6.526E-11	307
LOKIASV2_0185_ESMFold_hypothetical_protein	3e87-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3e87-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	0.142	291	230	10	300	2	270	1.644E-10	307
LOKIASV2_0185_ESMFold_hypothetical_protein	3c50-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3c50-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 2.6A	0.166	283	223	16	298	158	425	4.001E-11	307
LOKIASV2_0185_ESMFold_hypothetical_protein	4ztr-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4ztr-assembly1.cif.gz_A Human Aurora A catalytic domain bound to FK1141	0.154	283	203	16	298	7	247	3.716E-10	306
LOKIASV2_0185_ESMFold_hypothetical_protein	6ccy-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6ccy-assembly1.cif.gz_A Crystal structure of Akt1 in complex with a selective inhibitor	0.138	290	229	9	298	4	270	8.866E-10	306
LOKIASV2_0185_ESMFold_hypothetical_protein	5lih-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5lih-assembly1.cif.gz_A Structure of a peptide-substrate bound to PKCiota core kinase domain	0.157	289	219	10	298	2	262	3.333E-10	306
LOKIASV2_0185_ESMFold_hypothetical_protein	7z5n-assembly5.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	7z5n-assembly5.cif.gz_E Crystal structure of DYRK1A in complex with CX-4945	0.151	325	248	3	295	14	338	5.544E-11	306
LOKIASV2_0185_ESMFold_hypothetical_protein	6erv-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6erv-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp013	0.160	279	213	10	288	41	295	3.333E-10	306
LOKIASV2_0185_ESMFold_hypothetical_protein	5t5t-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5t5t-assembly1.cif.gz_A AMPK bound to allosteric activator	0.133	430	297	8	437	1	343	4.080E-12	306
LOKIASV2_0185_ESMFold_hypothetical_protein	3n9x-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3n9x-assembly1.cif.gz_B Crystal structure of Map Kinase from plasmodium berghei, PB000659.00.0	0.192	299	228	16	298	19	317	1.504E-11	306
LOKIASV2_0185_ESMFold_hypothetical_protein	2w5b-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2w5b-assembly1.cif.gz_A Human Nek2 kinase ATPgammaS-bound	0.162	272	210	16	287	6	257	3.399E-11	305
LOKIASV2_0185_ESMFold_hypothetical_protein	5fp6-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5fp6-assembly1.cif.gz_A Structure of cyclin-dependent kinase 2 with small-molecule ligand 3-(4,7-dichloro-1H-indol-3-yl)prop-2-yn-1-ol (AT17833) in an alternate binding site.	0.182	283	219	16	298	4	272	2.540E-10	305
LOKIASV2_0185_ESMFold_hypothetical_protein	3uyt-assembly6.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	3uyt-assembly6.cif.gz_C crystal structure of ck1d with PF670462 from P1 crystal form	0.149	285	227	13	297	4	271	1.935E-10	305
LOKIASV2_0185_ESMFold_hypothetical_protein	4dit-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4dit-assembly1.cif.gz_A Crystal Structure of GSK3beta in complex with a Imidazopyridine inhibitor	0.167	293	227	14	306	20	293	4.876E-10	305
LOKIASV2_0185_ESMFold_hypothetical_protein	5byy-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5byy-assembly1.cif.gz_A ERK5 IN COMPLEX WITH SMALL MOLECULE	0.168	295	241	16	306	7	301	1.677E-11	305
LOKIASV2_0185_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_E Heterodimeric structure of ERK2 and RSK1	0.191	325	245	3	306	3	327	1.278E-11	305
LOKIASV2_0185_ESMFold_hypothetical_protein	3c4w-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3c4w-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.7A	0.167	283	222	16	298	181	448	9.547E-11	305
LOKIASV2_0185_ESMFold_hypothetical_protein	8jmx-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8jmx-assembly1.cif.gz_A The crystal structure of human aurka kinase domain in complex with AURKA-A2	0.148	283	204	16	298	7	247	3.716E-10	304
LOKIASV2_0185_ESMFold_hypothetical_protein	4kb8-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4kb8-assembly3.cif.gz_C CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand	0.151	285	222	13	297	1	263	1.644E-10	304
LOKIASV2_0185_ESMFold_hypothetical_protein	8p7j-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	8p7j-assembly2.cif.gz_B Crystal structure of MAP2K6 with a covalent compound GCL96	0.156	285	215	16	300	9	264	2.682E-10	304
LOKIASV2_0185_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A CDK2 with compound 14 inhibitor with carboxylate	0.168	283	222	16	298	4	271	1.644E-10	304
LOKIASV2_0185_ESMFold_hypothetical_protein	5d7a-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5d7a-assembly2.cif.gz_B Crystal structure of the kinase domain of TRAF2 and NCK-interacting protein kinase with NCB-0846	0.166	290	219	16	305	15	277	7.275E-11	304
LOKIASV2_0185_ESMFold_hypothetical_protein	7nzy-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7nzy-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with CGS-15943	0.143	287	232	16	302	8	279	1.323E-10	304
LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly1.cif.gz_A Crystal structure of the kinase domain of CIPK23 T190D mutant	0.222	292	209	3	294	2	271	5.853E-11	304
LOKIASV2_0185_ESMFold_hypothetical_protein	3qkk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3qkk-assembly1.cif.gz_A Spirochromane Akt Inhibitors	0.155	290	225	9	298	1	267	9.042E-11	304
LOKIASV2_0185_ESMFold_hypothetical_protein	2f9g-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2f9g-assembly1.cif.gz_A Crystal structure of Fus3 phosphorylated on Tyr182	0.170	283	231	16	298	13	291	3.789E-11	304
LOKIASV2_0185_ESMFold_hypothetical_protein	4crs-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4crs-assembly1.cif.gz_A Human Protein Kinase N2 (PKN2, PRKCL2) in complex with ATPgammaS	0.156	296	230	2	297	1	274	1.229E-09	304
LOKIASV2_0185_ESMFold_hypothetical_protein	1q24-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1q24-assembly1.cif.gz_A PKA double mutant model of PKB in complex with MgATP	0.169	299	230	10	308	25	302	5.251E-11	304
LOKIASV2_0185_ESMFold_hypothetical_protein	4h3q-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4h3q-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.197	315	246	3	309	4	318	5.853E-11	304
LOKIASV2_0185_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	0.155	283	207	16	298	7	252	1.323E-10	303
LOKIASV2_0185_ESMFold_hypothetical_protein	4c3p-assembly1.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4c3p-assembly1.cif.gz_D Structure of dephosphorylated Aurora A (122-403) bound to TPX2 and AMPPCP	0.158	291	214	8	298	2	256	1.935E-10	303
LOKIASV2_0185_ESMFold_hypothetical_protein	2wtv-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2wtv-assembly2.cif.gz_B Aurora-A Inhibitor Structure	0.155	283	214	16	298	8	261	2.278E-10	303
LOKIASV2_0185_ESMFold_hypothetical_protein	7vto-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7vto-assembly2.cif.gz_B The crystal structure of PAK1 with the inhibitor GW8510	0.170	281	201	16	296	16	258	1.187E-10	303
LOKIASV2_0185_ESMFold_hypothetical_protein	5kz8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5kz8-assembly1.cif.gz_A Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	0.174	277	197	16	292	6	244	4.876E-10	303
LOKIASV2_0185_ESMFold_hypothetical_protein	4d2v-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4d2v-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	0.185	286	204	16	301	9	259	5.251E-11	303
LOKIASV2_0185_ESMFold_hypothetical_protein	6eir-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6eir-assembly2.cif.gz_B DYRK1A in complex with XMD15-27-2	0.148	314	243	4	289	17	330	1.253E-10	303
LOKIASV2_0185_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_A crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	0.155	285	237	14	294	20	304	2.405E-10	303
LOKIASV2_0185_ESMFold_hypothetical_protein	1o9u-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	1o9u-assembly1.cif.gz_A-2 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE	0.167	290	233	14	294	20	309	3.519E-10	303
LOKIASV2_0185_ESMFold_hypothetical_protein	4o0u-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4o0u-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	0.151	291	215	8	298	1	254	4.876E-10	302
LOKIASV2_0185_ESMFold_hypothetical_protein	7s47-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7s47-assembly1.cif.gz_A Integrin beta5(743-774)-linker-PAK4cat(D440N/S474E)	0.169	293	216	5	297	14	274	1.253E-10	302
LOKIASV2_0185_ESMFold_hypothetical_protein	1yhv-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1yhv-assembly1.cif.gz_A Crystal Structure of PAK1 kinase domain with two point mutations (K299R, T423E)	0.170	285	222	16	300	22	290	5.251E-11	302
LOKIASV2_0185_ESMFold_hypothetical_protein	5izj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5izj-assembly1.cif.gz_A Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	0.159	279	214	10	288	25	279	1.323E-10	302
LOKIASV2_0185_ESMFold_hypothetical_protein	2gnj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2gnj-assembly1.cif.gz_A PKA three fold mutant model of Rho-kinase with Y-27632	0.156	289	220	10	298	25	286	1.736E-10	302
LOKIASV2_0185_ESMFold_hypothetical_protein	3c4x-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3c4x-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.9A	0.146	292	243	6	297	140	425	8.111E-11	302
LOKIASV2_0185_ESMFold_hypothetical_protein	4m3q-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4m3q-assembly1.cif.gz_A Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with inhibitor UNC1917	0.171	282	192	16	297	10	242	3.157E-10	301
LOKIASV2_0185_ESMFold_hypothetical_protein	6ccf-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6ccf-assembly2.cif.gz_B Crystal Structure of the Human CAMKK1A in complex with Hesperadin	0.190	279	206	10	288	1	255	4.460E-11	301
LOKIASV2_0185_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP	0.202	280	186	16	295	7	240	2.158E-10	301
LOKIASV2_0185_ESMFold_hypothetical_protein	5lqf-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	5lqf-assembly2.cif.gz_D CDK1/CyclinB1/CKS2 in complex with NU6102	0.165	283	232	16	298	7	285	1.253E-10	301
LOKIASV2_0185_ESMFold_hypothetical_protein	2vu3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2vu3-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.	0.170	283	225	16	298	4	275	2.043E-10	301
LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_D Crystal structure of the kinase domain of CIPK23 T190D mutant	0.204	284	209	11	294	9	271	3.219E-11	301
LOKIASV2_0185_ESMFold_hypothetical_protein	6a1c-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6a1c-assembly1.cif.gz_A Crystal structure of the CK2a1-go289 complex	0.188	296	236	16	307	38	333	9.736E-12	301
LOKIASV2_0185_ESMFold_hypothetical_protein	4nct-assembly5.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4nct-assembly5.cif.gz_B Human DYRK1A in complex with PKC412	0.148	317	249	4	296	17	333	1.736E-10	301
LOKIASV2_0185_ESMFold_hypothetical_protein	3fhi-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3fhi-assembly1.cif.gz_A Crystal structure of a complex between the catalytic and regulatory (RI{alpha}) subunits of PKA	0.172	279	210	10	288	26	280	2.831E-10	301
LOKIASV2_0185_ESMFold_hypothetical_protein	3cok-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3cok-assembly1.cif.gz_A Crystal structure of PLK4 kinase	0.183	281	180	16	296	13	233	8.866E-10	300
LOKIASV2_0185_ESMFold_hypothetical_protein	4g34-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4g34-assembly1.cif.gz_A Crystal Structure of GSK6924 Bound to PERK (R587-R1092, delete A660-T867) at 2.70 A Resolution	0.187	272	190	16	287	7	241	3.519E-10	300
LOKIASV2_0185_ESMFold_hypothetical_protein	1zys-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1zys-assembly1.cif.gz_A Co-crystal structure of Checkpoint Kinase Chk1 with a pyrrolo-pyridine inhibitor	0.185	273	205	16	288	7	258	1.527E-09	300
LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH COMPOUND 12	0.178	272	201	10	281	63	308	7.953E-10	300
LOKIASV2_0185_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6pme-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND	0.170	292	220	5	296	1	266	1.187E-10	299
LOKIASV2_0185_ESMFold_hypothetical_protein	6b16-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6b16-assembly2.cif.gz_B P21-activated kinase 1 in complex with a 4-azaindole inhibitor	0.162	285	219	16	300	16	277	1.397E-10	299
LOKIASV2_0185_ESMFold_hypothetical_protein	2fvd-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2fvd-assembly1.cif.gz_A Cyclin Dependent Kinase 2 (CDK2) with diaminopyrimidine inhibitor	0.172	283	224	16	298	4	274	5.740E-10	299
LOKIASV2_0185_ESMFold_hypothetical_protein	5w4w-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	5w4w-assembly3.cif.gz_C Identification and Profiling of a Selective and Brain Penetrant Radioligand for In Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors	0.151	285	226	13	297	4	270	2.405E-10	299
LOKIASV2_0185_ESMFold_hypothetical_protein	2itt-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2itt-assembly1.cif.gz_A Crystal structure of EGFR kinase domain L858R mutation in complex with AEE788	0.160	292	220	10	301	11	273	4.973E-11	299
LOKIASV2_0185_ESMFold_hypothetical_protein	7cga-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	7cga-assembly3.cif.gz_C Crystal structure of human unphosphorylated p38gamma	0.193	318	247	3	309	1	318	1.146E-11	299
LOKIASV2_0185_ESMFold_hypothetical_protein	2vd5-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	2vd5-assembly1.cif.gz_A-2 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	0.169	297	237	9	305	55	340	1.557E-10	299
LOKIASV2_0185_ESMFold_hypothetical_protein	3c4z-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	3c4z-assembly1.cif.gz_A-2 Crystal structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 1.84A	0.167	275	218	16	290	154	416	1.253E-10	299
LOKIASV2_0185_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	0.153	284	208	16	299	6	251	2.831E-10	298
LOKIASV2_0185_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6oyw-assembly2.cif.gz_B ASK1 kinase domain in complex with Compound 11	0.172	272	203	16	287	3	248	1.935E-10	298
LOKIASV2_0185_ESMFold_hypothetical_protein	6cd6-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6cd6-assembly3.cif.gz_C Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.191	278	208	11	288	1	258	6.180E-11	298
LOKIASV2_0185_ESMFold_hypothetical_protein	3g33-assembly1.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	3g33-assembly1.cif.gz_C Crystal structure of CDK4/cyclin D3	0.150	286	232	16	289	2	287	1.833E-10	298
LOKIASV2_0185_ESMFold_hypothetical_protein	7aj8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7aj8-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 25	0.162	327	245	3	295	1	327	1.064E-10	298
LOKIASV2_0185_ESMFold_hypothetical_protein	3qkm-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3qkm-assembly1.cif.gz_A Spirocyclic sulfonamides as AKT inhibitors	0.147	290	227	9	298	1	267	2.990E-10	298
LOKIASV2_0185_ESMFold_hypothetical_protein	6jkm-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6jkm-assembly1.cif.gz_A Crystal structure of BubR1 kinase domain	0.156	299	241	1	299	34	319	7.682E-11	298
LOKIASV2_0185_ESMFold_hypothetical_protein	5ntj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ntj-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compound RKp032	0.171	279	211	10	288	41	295	2.158E-10	298
LOKIASV2_0185_ESMFold_hypothetical_protein	6yqj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6yqj-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with open-chain Fasudil-derivative 2-[isoquinolin-5-ylsulfonyl(propyl)amino]ethylazanium (soaked)	0.163	288	226	10	297	38	308	2.043E-10	298
LOKIASV2_0185_ESMFold_hypothetical_protein	4xey-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4xey-assembly2.cif.gz_B Crystal structure of an SH2-kinase domain construct of c-Abl tyrosine kinase	0.189	282	201	16	297	106	354	7.682E-11	298
LOKIASV2_0185_ESMFold_hypothetical_protein	8fe2-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	8fe2-assembly2.cif.gz_B Structure of J-PKAc chimera complexed with Aplithianine A	0.171	275	208	16	290	96	347	3.333E-10	298
LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly1.cif.gz_A CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.188	286	209	14	299	6	263	1.397E-10	298
LOKIASV2_0185_ESMFold_hypothetical_protein	4l9i-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4l9i-assembly1.cif.gz_A Bovine G Protein Coupled Receptor Kinase 1 in Complex with Paroxetine	0.160	293	232	6	298	149	425	3.219E-11	298
LOKIASV2_0185_ESMFold_hypothetical_protein	2c6e-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2c6e-assembly2.cif.gz_B Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	0.145	284	203	16	299	7	244	1.297E-09	297
LOKIASV2_0185_ESMFold_hypothetical_protein	5wdy-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5wdy-assembly2.cif.gz_B Crystal structure of WNK1 in complex with 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine (compound 6)	0.186	274	194	14	287	14	252	3.789E-11	297
LOKIASV2_0185_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	0.169	285	211	13	297	19	273	2.084E-11	297
LOKIASV2_0185_ESMFold_hypothetical_protein	6ej4-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6ej4-assembly3.cif.gz_C DYRK1A in complex with XMD7-112	0.141	318	251	3	295	14	331	6.526E-11	297
LOKIASV2_0185_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_B crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	0.141	284	241	14	294	20	303	2.540E-10	297
LOKIASV2_0185_ESMFold_hypothetical_protein	3i7b-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3i7b-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor NM-PP1	0.201	287	209	13	299	4	266	1.935E-10	297
LOKIASV2_0185_ESMFold_hypothetical_protein	8boc-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8boc-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 19	0.183	297	212	1	297	1	260	4.374E-10	296
LOKIASV2_0185_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP	0.155	286	232	16	301	7	282	1.187E-10	296
LOKIASV2_0185_ESMFold_hypothetical_protein	2r0i-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2r0i-assembly2.cif.gz_B Crystal structure of a kinase MARK2/Par-1 mutant	0.177	285	198	16	300	6	247	6.399E-10	296
LOKIASV2_0185_ESMFold_hypothetical_protein	4otd-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4otd-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain	0.156	290	234	8	297	4	281	7.532E-10	296
LOKIASV2_0185_ESMFold_hypothetical_protein	4f0g-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4f0g-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain from D. discoideum	0.180	278	206	16	293	11	262	1.297E-09	295
LOKIASV2_0185_ESMFold_hypothetical_protein	4f0f-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4f0f-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain bound to AppCp from D. discoideum	0.173	278	219	16	293	10	275	1.736E-10	295
LOKIASV2_0185_ESMFold_hypothetical_protein	8p7j-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8p7j-assembly1.cif.gz_A Crystal structure of MAP2K6 with a covalent compound GCL96	0.153	285	214	16	300	9	262	9.885E-10	295
LOKIASV2_0185_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A Crystal structure of CDK2 liganded with compound WN316	0.171	283	223	16	298	2	271	3.716E-10	295
LOKIASV2_0185_ESMFold_hypothetical_protein	1cki-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	1cki-assembly1.cif.gz_B RECOMBINANT CASEIN KINASE I DELTA TRUNCATION MUTANT CONTAINING RESIDUES 1-317	0.153	290	230	8	297	1	272	2.004E-09	295
LOKIASV2_0185_ESMFold_hypothetical_protein	6pxp-assembly3.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6pxp-assembly3.cif.gz_A Human Casein Kinase 1 delta Site 2 mutant (K171E)	0.165	295	228	3	297	1	274	6.060E-10	295
LOKIASV2_0185_ESMFold_hypothetical_protein	3v04-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3v04-assembly1.cif.gz_A Discovery of Novel Allosteric MEK Inhibitors Possessing Classical and Non-classical Bidentate Ser212 Interactions.	0.186	293	221	8	300	1	272	2.278E-10	295
LOKIASV2_0185_ESMFold_hypothetical_protein	3fy0-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3fy0-assembly1.cif.gz_A Crystal structure of PAK1 kinase domain with ruthenium complex DW1	0.177	277	204	20	296	26	274	8.111E-11	295
LOKIASV2_0185_ESMFold_hypothetical_protein	1syk-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	1syk-assembly2.cif.gz_B Crystal structure of E230Q mutant of cAMP-dependent protein kinase reveals unexpected apoenzyme conformation	0.156	291	227	10	300	26	295	2.682E-10	295
LOKIASV2_0185_ESMFold_hypothetical_protein	6s11-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6s11-assembly2.cif.gz_B Crystal Structure of DYRK1A with small molecule inhibitor	0.162	316	245	3	295	13	328	1.557E-10	295
LOKIASV2_0185_ESMFold_hypothetical_protein	5o5m-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5o5m-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp117	0.162	281	215	10	290	30	286	5.740E-10	295
LOKIASV2_0185_ESMFold_hypothetical_protein	2qur-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2qur-assembly1.cif.gz_A Crystal Structure of F327A/K285P Mutant of cAMP-dependent Protein Kinase	0.165	299	231	10	308	28	305	1.323E-10	295
LOKIASV2_0185_ESMFold_hypothetical_protein	4xhg-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4xhg-assembly1.cif.gz_A Structure of C. glabrata Hrr25 bound to ADP (formate condition)	0.160	293	239	10	302	2	286	5.149E-10	295
LOKIASV2_0185_ESMFold_hypothetical_protein	4pni-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	4pni-assembly1.cif.gz_A-2 Bovine G protein-coupled receptor kinase 1 in complex with GSK2163632A	0.169	283	222	16	298	158	425	3.399E-11	295
LOKIASV2_0185_ESMFold_hypothetical_protein	4wnk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4wnk-assembly1.cif.gz_A Crystal Structure of Bovine G Protein Coupled-Receptor Kinase 5 in Complex with CCG215022	0.151	292	239	6	297	154	436	7.275E-11	295
LOKIASV2_0185_ESMFold_hypothetical_protein	3nyn-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3nyn-assembly1.cif.gz_A Crystal Structure of G Protein-Coupled Receptor Kinase 6 in Complex with Sangivamycin	0.149	292	237	6	297	176	455	2.278E-10	295
LOKIASV2_0185_ESMFold_hypothetical_protein	4x7h-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4x7h-assembly1.cif.gz_A Co-crystal Structure of PERK bound to N-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxamide inhibitor	0.184	276	193	16	291	9	246	7.532E-10	294
LOKIASV2_0185_ESMFold_hypothetical_protein	1r1w-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1r1w-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET	0.171	282	201	16	297	27	270	1.253E-10	294
LOKIASV2_0185_ESMFold_hypothetical_protein	6gro-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6gro-assembly1.cif.gz_A Human CSNK1G3 bound to SB-223133	0.150	289	235	16	304	7	284	3.157E-10	294
LOKIASV2_0185_ESMFold_hypothetical_protein	6uip-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6uip-assembly1.cif.gz_A DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.	0.157	326	245	4	295	19	344	1.323E-10	294
LOKIASV2_0185_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	0.185	282	204	14	295	14	264	1.935E-10	293
LOKIASV2_0185_ESMFold_hypothetical_protein	5cen-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5cen-assembly1.cif.gz_A Crystal structure of DLK (kinase domain)	0.190	297	205	1	297	1	254	8.111E-11	293
LOKIASV2_0185_ESMFold_hypothetical_protein	3r9o-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3r9o-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-143	0.173	283	222	16	298	4	272	5.436E-10	293
LOKIASV2_0185_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	0.174	285	202	16	300	3	247	9.885E-10	293
LOKIASV2_0185_ESMFold_hypothetical_protein	5ih9-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ih9-assembly1.cif.gz_A MELK in complex with NVS-MELK8A	0.172	286	199	16	301	10	250	2.831E-10	293
LOKIASV2_0185_ESMFold_hypothetical_protein	6dd4-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6dd4-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	0.108	306	268	3	304	1	306	3.333E-10	293
LOKIASV2_0185_ESMFold_hypothetical_protein	1o6k-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1o6k-assembly1.cif.gz_A Structure of activated form of PKB kinase domain S474D with GSK3 peptide and AMP-PNP	0.147	286	223	10	295	2	263	4.618E-10	293
LOKIASV2_0185_ESMFold_hypothetical_protein	4h3p-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4h3p-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.200	304	238	1	304	8	305	1.349E-11	293
LOKIASV2_0185_ESMFold_hypothetical_protein	5cyz-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5cyz-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 1	0.155	288	233	9	296	3	279	1.008E-10	293
LOKIASV2_0185_ESMFold_hypothetical_protein	4fi1-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4fi1-assembly1.cif.gz_A Crystal structure of scCK2 alpha in complex with ATP	0.145	331	247	16	305	40	370	5.544E-11	293
LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly4.cif.gz_G	LOKIASV2_0185_ESMFold_hypothetical_protein	4yga-assembly4.cif.gz_G CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	0.188	287	209	13	299	5	263	2.278E-10	293
LOKIASV2_0185_ESMFold_hypothetical_protein	5w8r-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5w8r-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor 3CIB-PPI	0.189	287	212	13	299	6	268	2.682E-10	293
LOKIASV2_0185_ESMFold_hypothetical_protein	4l9i-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4l9i-assembly1.cif.gz_B Bovine G Protein Coupled Receptor Kinase 1 in Complex with Paroxetine	0.159	282	232	16	297	157	433	2.453E-11	293
LOKIASV2_0185_ESMFold_hypothetical_protein	3op5-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	3op5-assembly3.cif.gz_C Human vaccinia-related kinase 1	0.110	303	268	3	304	1	303	1.935E-10	292
LOKIASV2_0185_ESMFold_hypothetical_protein	7aj5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7aj5-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 10	0.159	327	245	4	295	1	327	2.043E-10	292
LOKIASV2_0185_ESMFold_hypothetical_protein	2j50-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2j50-assembly2.cif.gz_B Structure of Aurora-2 in complex with PHA-739358	0.145	290	210	10	299	1	247	1.612E-09	291
LOKIASV2_0185_ESMFold_hypothetical_protein	4zy6-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4zy6-assembly2.cif.gz_B Crystal structure of P21-activated kinase 1 in complex with an inhibitor compound 29	0.165	285	217	16	300	16	276	2.158E-10	291
LOKIASV2_0185_ESMFold_hypothetical_protein	7ozd-assembly1.cif.gz_AAA	LOKIASV2_0185_ESMFold_hypothetical_protein	7ozd-assembly1.cif.gz_AAA FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 34.	0.174	277	227	20	296	1	276	1.557E-10	291
LOKIASV2_0185_ESMFold_hypothetical_protein	6nyb-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6nyb-assembly1.cif.gz_B Structure of a MAPK pathway complex	0.184	295	218	6	300	4	271	1.397E-10	291
LOKIASV2_0185_ESMFold_hypothetical_protein	4d2v-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4d2v-assembly1.cif.gz_B Structure of MELK in complex with inhibitors	0.179	286	204	16	301	10	258	1.323E-10	291
LOKIASV2_0185_ESMFold_hypothetical_protein	6npz-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6npz-assembly2.cif.gz_B Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate	0.140	290	229	9	298	4	270	7.532E-10	291
LOKIASV2_0185_ESMFold_hypothetical_protein	2gu8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2gu8-assembly1.cif.gz_A Discovery of 2-Pyrimidyl-5-Amidothiophenes as Novel and Potent Inhibitors for AKT: Synthesis and SAR Studies	0.157	299	234	10	308	25	302	5.544E-11	291
LOKIASV2_0185_ESMFold_hypothetical_protein	4aw2-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	4aw2-assembly1.cif.gz_A-2 Crystal structure of CDC42 binding protein kinase alpha (MRCK alpha)	0.146	288	241	9	296	70	352	3.519E-10	291
LOKIASV2_0185_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_A Structure of Mnk1 in complex with DS12881479	0.194	275	185	16	290	8	237	7.134E-10	290
LOKIASV2_0185_ESMFold_hypothetical_protein	4x7j-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4x7j-assembly1.cif.gz_A Co-crystal Structure of PERK with 2-amino-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6-yl]benzamide inhibitor	0.180	280	198	16	295	9	251	7.953E-10	290
LOKIASV2_0185_ESMFold_hypothetical_protein	4kbk-assembly5.cif.gz_B-2	LOKIASV2_0185_ESMFold_hypothetical_protein	4kbk-assembly5.cif.gz_B-2 CK1d in complex with (3S)-3-{4-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]pyridin-2-yl}morpholine inhibitor	0.160	293	237	10	302	1	283	3.716E-10	290
LOKIASV2_0185_ESMFold_hypothetical_protein	2hak-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	2hak-assembly4.cif.gz_D Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.149	285	211	16	300	7	255	4.142E-10	290
LOKIASV2_0185_ESMFold_hypothetical_protein	3d0e-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3d0e-assembly1.cif.gz_A Crystal structure of human Akt2 in complex with GSK690693	0.142	291	230	10	300	2	270	5.436E-10	290
LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_A ROCK2 IN COMPLEX WITH COMPOUND 12	0.168	272	206	10	281	64	311	8.866E-10	290
LOKIASV2_0185_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_B Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	0.179	283	213	9	291	66	326	1.527E-09	290
LOKIASV2_0185_ESMFold_hypothetical_protein	5tc0-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5tc0-assembly1.cif.gz_A Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate	0.172	282	188	16	297	10	237	9.885E-10	289
LOKIASV2_0185_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 1 (dovitinib)	0.147	284	211	16	299	7	254	1.736E-10	289
LOKIASV2_0185_ESMFold_hypothetical_protein	4zji-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4zji-assembly1.cif.gz_A PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	0.171	277	200	16	292	17	258	4.618E-10	289
LOKIASV2_0185_ESMFold_hypothetical_protein	3vn9-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3vn9-assembly1.cif.gz_A Rifined Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state	0.148	285	229	10	294	5	274	2.990E-10	289
LOKIASV2_0185_ESMFold_hypothetical_protein	3qkl-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3qkl-assembly1.cif.gz_A Spirochromane Akt Inhibitors	0.161	289	222	9	297	1	266	5.740E-10	289
LOKIASV2_0185_ESMFold_hypothetical_protein	1rdq-assembly1.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	1rdq-assembly1.cif.gz_E Hydrolysis of ATP in the crystal of Y204A mutant of cAMP-dependent protein kinase	0.166	279	212	10	288	30	284	2.990E-10	289
LOKIASV2_0185_ESMFold_hypothetical_protein	2x7g-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2x7g-assembly1.cif.gz_A Structure of human serine-arginine-rich protein-specific kinase 2 (SRPK2) bound to purvalanol B	0.136	343	250	3	292	1	343	2.405E-10	289
LOKIASV2_0185_ESMFold_hypothetical_protein	7dd1-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7dd1-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with a peptide inhibitor	0.142	348	252	4	298	4	351	2.043E-10	289
LOKIASV2_0185_ESMFold_hypothetical_protein	3o50-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3o50-assembly1.cif.gz_A Crystal structure of benzamide 9 bound to AuroraA	0.148	291	207	8	298	1	244	2.932E-09	288
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H	LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.161	272	202	16	287	7	248	2.831E-10	288
LOKIASV2_0185_ESMFold_hypothetical_protein	2cgu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2cgu-assembly1.cif.gz_A Identification of chemically diverse Chk1 inhibitors by receptor- based virtual screening	0.186	273	202	16	288	4	252	2.630E-09	288
LOKIASV2_0185_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A Crystal structure of the Kinase domain of WNK1	0.189	280	209	16	295	11	269	3.157E-10	288
LOKIASV2_0185_ESMFold_hypothetical_protein	1h08-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1h08-assembly1.cif.gz_A CDK2 in complex with a disubstituted 2, 4-bis anilino pyrimidine CDK4 inhibitor	0.189	283	218	16	298	4	273	4.374E-10	288
LOKIASV2_0185_ESMFold_hypothetical_protein	5osj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5osj-assembly1.cif.gz_A Cdk2(WT) with covalent adduct at C177	0.183	283	230	16	298	3	284	3.519E-10	288
LOKIASV2_0185_ESMFold_hypothetical_protein	6yl6-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6yl6-assembly1.cif.gz_A Cdk2(F80C)	0.180	285	231	16	298	9	293	2.405E-10	288
LOKIASV2_0185_ESMFold_hypothetical_protein	5x28-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5x28-assembly1.cif.gz_A Crystal structure of EGFR 696-1022 L858R in complex with SKLB(6)	0.159	295	223	16	310	16	281	2.043E-10	288
LOKIASV2_0185_ESMFold_hypothetical_protein	5izj-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5izj-assembly2.cif.gz_B Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	0.161	279	213	10	288	25	279	2.831E-10	288
LOKIASV2_0185_ESMFold_hypothetical_protein	7jnt-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7jnt-assembly1.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.162	298	210	10	307	65	315	3.923E-10	288
LOKIASV2_0185_ESMFold_hypothetical_protein	6c9d-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6c9d-assembly2.cif.gz_B Crystal structure of KA1-autoinhibited MARK1 kinase	0.132	422	343	16	437	8	403	1.453E-12	288
LOKIASV2_0185_ESMFold_hypothetical_protein	2h6d-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2h6d-assembly1.cif.gz_A Protein Kinase Domain of the Human 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK alpha-2 chain)	0.179	287	208	9	295	1	254	3.716E-10	287
LOKIASV2_0185_ESMFold_hypothetical_protein	3oxz-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3oxz-assembly1.cif.gz_A Crystal structure of ABL kinase domain bound with a DFG-out inhibitor AP24534	0.195	282	194	16	297	15	256	2.831E-10	287
LOKIASV2_0185_ESMFold_hypothetical_protein	1zmw-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	1zmw-assembly1.cif.gz_B Catalytic and ubiqutin-associated domains of MARK2/PAR-1: T208A/S212A inactive double mutant	0.163	286	205	16	301	6	251	4.374E-10	287
LOKIASV2_0185_ESMFold_hypothetical_protein	6eis-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6eis-assembly3.cif.gz_C DYRK1A in complex with JWC-055	0.158	327	246	3	295	14	340	1.397E-10	287
LOKIASV2_0185_ESMFold_hypothetical_protein	6byr-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6byr-assembly1.cif.gz_A Structures of the PKA RI alpha holoenzyme with the FLHCC driver J-PKAc alpha or native PKAc alpha	0.168	279	211	10	288	93	347	1.935E-10	287
LOKIASV2_0185_ESMFold_hypothetical_protein	4mvf-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4mvf-assembly1.cif.gz_A Crystal Structure of Plasmodium falciparum CDPK2 complexed with inhibitor staurosporine	0.192	292	183	8	299	5	231	4.618E-10	287
LOKIASV2_0185_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.170	265	190	16	280	8	237	1.797E-09	286
LOKIASV2_0185_ESMFold_hypothetical_protein	3dbf-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3dbf-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 562	0.133	297	212	2	298	1	245	4.528E-09	286
LOKIASV2_0185_ESMFold_hypothetical_protein	2cn5-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	2cn5-assembly1.cif.gz_A-2 Crystal structure of human Chk2 in complex with ADP	0.205	288	205	13	300	11	269	2.990E-10	286
LOKIASV2_0185_ESMFold_hypothetical_protein	3e8n-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3e8n-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) complexed with a potent inhibitor RDEA119 and MgATP	0.183	285	217	16	300	8	274	2.682E-10	286
LOKIASV2_0185_ESMFold_hypothetical_protein	3op5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3op5-assembly1.cif.gz_A Human vaccinia-related kinase 1	0.120	313	264	4	304	3	315	7.134E-10	286
LOKIASV2_0185_ESMFold_hypothetical_protein	1rej-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1rej-assembly1.cif.gz_A Crystal structure of cAMP-dependent protein kinase complexed with balanol analog 1	0.165	291	220	10	300	23	286	7.532E-10	286
LOKIASV2_0185_ESMFold_hypothetical_protein	6fad-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6fad-assembly4.cif.gz_D SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.144	341	247	3	292	15	355	1.397E-10	286
LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_C-3	LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_C-3 ROCK2 IN COMPLEX WITH COMPOUND 12	0.173	272	199	10	281	65	306	8.397E-10	286
LOKIASV2_0185_ESMFold_hypothetical_protein	5t6i-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5t6i-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TGCDPK1 FROM TOXOPLASMA GONDII COMPLEXED WITH 5GB	0.200	289	209	13	301	6	267	3.519E-10	286
LOKIASV2_0185_ESMFold_hypothetical_protein	2bmc-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	2bmc-assembly4.cif.gz_D Aurora-2 T287D T288D complexed with PHA-680632	0.147	284	206	16	299	7	248	6.060E-10	285
LOKIASV2_0185_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	7qq6-assembly2.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 1 (dovitinib)	0.146	265	208	16	280	7	250	6.890E-11	285
LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly1.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly1.cif.gz_C Crystal structure of the kinase domain of CIPK23 T190D mutant	0.208	282	204	16	297	5	262	3.519E-10	285
LOKIASV2_0185_ESMFold_hypothetical_protein	2uzt-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2uzt-assembly1.cif.gz_A PKA structures of AKT, indazole-pyridine inhibitors	0.158	288	227	10	297	24	294	3.716E-10	285
LOKIASV2_0185_ESMFold_hypothetical_protein	4dg3-assembly1.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	4dg3-assembly1.cif.gz_E Crystal structure of R336A mutant of cAMP-dependent protein kinase with unphosphorylated turn motif.	0.168	279	211	10	288	25	279	3.716E-10	285
LOKIASV2_0185_ESMFold_hypothetical_protein	4f1m-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4f1m-assembly1.cif.gz_A Crystal Structure of the G1179S Roco4 Kinase Domain bound to AppCp from D. discoideum.	0.182	284	225	10	293	2	277	1.044E-09	284
LOKIASV2_0185_ESMFold_hypothetical_protein	4wua-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4wua-assembly1.cif.gz_A Crystal structure of human SRPK1 complexed to an inhibitor SRPIN340	0.144	343	251	3	296	1	343	3.716E-10	284
LOKIASV2_0185_ESMFold_hypothetical_protein	6eh2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6eh2-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp032 and AMP	0.158	279	211	10	288	41	292	1.702E-09	284
LOKIASV2_0185_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	0.165	298	215	10	307	65	322	5.436E-10	284
LOKIASV2_0185_ESMFold_hypothetical_protein	3i79-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3i79-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1)	0.201	287	209	13	299	5	267	6.756E-10	284
LOKIASV2_0185_ESMFold_hypothetical_protein	4umr-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4umr-assembly1.cif.gz_A Structure of MELK in complex with inhibitors	0.178	283	197	16	298	6	246	3.923E-10	283
LOKIASV2_0185_ESMFold_hypothetical_protein	6una-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6una-assembly1.cif.gz_A Crystal structure of inactive p38gamma	0.186	298	230	1	298	11	293	1.475E-10	283
LOKIASV2_0185_ESMFold_hypothetical_protein	3nx8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3nx8-assembly1.cif.gz_A human cAMP dependent protein kinase in complex with phenol	0.151	288	220	10	297	24	283	4.876E-10	283
LOKIASV2_0185_ESMFold_hypothetical_protein	1ydt-assembly1.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	1ydt-assembly1.cif.gz_E STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE	0.156	279	214	10	288	24	278	2.682E-10	283
LOKIASV2_0185_ESMFold_hypothetical_protein	7zks-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7zks-assembly1.cif.gz_A SRPK1 IN COMPLEX WITH INHIBITOR	0.144	345	252	4	298	4	348	1.833E-10	283
LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly3.cif.gz_E-4	LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly3.cif.gz_E-4 ROCK2 IN COMPLEX WITH COMPOUND 12	0.165	272	206	10	281	65	312	1.297E-09	283
LOKIASV2_0185_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_A ROCK 1 bound to methoxyphenyl thiazole inhibitor	0.172	299	215	9	307	65	325	7.953E-10	283
LOKIASV2_0185_ESMFold_hypothetical_protein	2vv9-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2vv9-assembly1.cif.gz_A CDK2 in complex with an imidazole piperazine	0.186	283	216	16	298	4	269	9.362E-10	282
LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23	0.206	284	206	16	299	10	269	3.923E-10	282
LOKIASV2_0185_ESMFold_hypothetical_protein	3pj8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3pj8-assembly1.cif.gz_A Structure of CDK2 in complex with a Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine.	0.183	283	223	16	298	5	278	7.953E-10	282
LOKIASV2_0185_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_D Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	0.149	278	213	20	297	18	268	2.234E-09	282
LOKIASV2_0185_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A Cdk2(F80C) with Covalent Adduct TK22 at F80C	0.174	283	228	16	298	9	285	6.756E-10	282
LOKIASV2_0185_ESMFold_hypothetical_protein	4l6q-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4l6q-assembly1.cif.gz_A ROCK2 in complex with benzoxaborole	0.167	298	219	10	307	61	324	9.885E-10	282
LOKIASV2_0185_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2)	0.155	283	207	16	298	7	252	3.847E-09	281
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly7.cif.gz_G	LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly7.cif.gz_G GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.152	270	200	16	285	7	243	1.612E-09	281
LOKIASV2_0185_ESMFold_hypothetical_protein	5osm-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5osm-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent adduct at C80	0.170	283	229	16	298	8	284	5.436E-10	281
LOKIASV2_0185_ESMFold_hypothetical_protein	6cqh-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6cqh-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor	0.115	299	255	3	291	1	299	1.475E-10	281
LOKIASV2_0185_ESMFold_hypothetical_protein	6bu6-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6bu6-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a bis-difluorophenol-aminopyridine inhibitor	0.117	313	266	3	304	1	313	5.740E-10	281
LOKIASV2_0185_ESMFold_hypothetical_protein	4mq2-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4mq2-assembly2.cif.gz_B The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.163	323	244	4	295	15	337	1.064E-10	281
LOKIASV2_0185_ESMFold_hypothetical_protein	5czo-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5czo-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	0.160	288	230	9	296	3	277	2.540E-10	281
LOKIASV2_0185_ESMFold_hypothetical_protein	2hw6-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2hw6-assembly1.cif.gz_A Crystal structure of Mnk1 catalytic domain	0.186	280	186	16	295	10	239	2.932E-09	280
LOKIASV2_0185_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK24/SOS2	0.209	279	198	16	294	5	255	1.229E-09	280
LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_D Crystal structure of the kinase domain of CIPK23	0.206	271	197	16	286	13	261	1.935E-10	280
LOKIASV2_0185_ESMFold_hypothetical_protein	6egw-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6egw-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp017 and RKp117	0.167	291	225	10	300	26	296	3.519E-10	280
LOKIASV2_0185_ESMFold_hypothetical_protein	3f7z-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3f7z-assembly2.cif.gz_B X-ray Co-Crystal Structure of Glycogen Synthase Kinase 3beta in Complex with an Inhibitor	0.159	281	235	14	294	21	300	1.297E-09	280
LOKIASV2_0185_ESMFold_hypothetical_protein	3krw-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3krw-assembly1.cif.gz_A Human GRK2 in complex with Gbetgamma subunits and balanol (soak)	0.126	430	372	6	432	151	580	9.929E-13	280
LOKIASV2_0185_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	0.171	266	192	16	281	8	240	8.397E-10	279
LOKIASV2_0185_ESMFold_hypothetical_protein	4lg4-assembly6.cif.gz_F	LOKIASV2_0185_ESMFold_hypothetical_protein	4lg4-assembly6.cif.gz_F Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.201	290	194	16	305	10	253	4.876E-10	279
LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23 T190D mutant	0.205	282	204	16	297	11	268	2.158E-10	279
LOKIASV2_0185_ESMFold_hypothetical_protein	4otg-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4otg-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Lestaurtinib	0.169	304	241	8	311	4	294	1.102E-09	279
LOKIASV2_0185_ESMFold_hypothetical_protein	2h9v-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2h9v-assembly1.cif.gz_A Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y27632	0.174	296	216	10	305	63	324	8.866E-10	279
LOKIASV2_0185_ESMFold_hypothetical_protein	6csw-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6csw-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N-methyl-N-propyl-dihydropteridine inhibitor	0.110	303	267	4	304	1	303	1.102E-09	278
LOKIASV2_0185_ESMFold_hypothetical_protein	2jdo-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2jdo-assembly1.cif.gz_A STRUCTURE OF PKB-BETA (AKT2) COMPLEXED WITH ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY) ETHYLAMINO)ETHYL)AMIDE	0.152	301	236	10	310	2	280	5.149E-10	278
LOKIASV2_0185_ESMFold_hypothetical_protein	3o7l-assembly1.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	3o7l-assembly1.cif.gz_D Crystal Structure of phospholamban (1-19):PKA C-subunit:AMP-PNP:Mg2+ complex	0.153	291	230	10	300	26	297	2.004E-09	278
LOKIASV2_0185_ESMFold_hypothetical_protein	3qal-assembly1.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	3qal-assembly1.cif.gz_E Crystal Structure of Arg280Ala mutant of Catalytic subunit of cAMP-dependent Protein Kinase	0.155	285	220	16	300	34	294	5.149E-10	278
LOKIASV2_0185_ESMFold_hypothetical_protein	5xv7-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5xv7-assembly1.cif.gz_A SRPK1 in complex with Alectinib	0.146	347	251	4	298	4	350	2.405E-10	278
LOKIASV2_0185_ESMFold_hypothetical_protein	6fad-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6fad-assembly3.cif.gz_C SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.143	344	248	3	292	15	358	2.405E-10	278
LOKIASV2_0185_ESMFold_hypothetical_protein	5wng-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	5wng-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.180	272	200	9	280	67	311	4.289E-09	278
LOKIASV2_0185_ESMFold_hypothetical_protein	4uak-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	4uak-assembly1.cif.gz_A-2 MRCK beta in complex with ADP	0.161	266	211	16	281	78	330	5.740E-10	278
LOKIASV2_0185_ESMFold_hypothetical_protein	3uzt-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3uzt-assembly1.cif.gz_A Structure of the C13.18 RNA Aptamer in Complex with G Protein-Coupled Receptor Kinase 2	0.143	437	358	6	442	153	571	1.619E-12	278
LOKIASV2_0185_ESMFold_hypothetical_protein	1muo-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1muo-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE	0.145	284	208	16	299	6	249	4.062E-09	277
LOKIASV2_0185_ESMFold_hypothetical_protein	3dv3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3dv3-assembly1.cif.gz_A MEK1 with PF-04622664 Bound	0.181	291	219	10	300	3	271	8.397E-10	277
LOKIASV2_0185_ESMFold_hypothetical_protein	7n91-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7n91-assembly1.cif.gz_A P70 S6K1 IN COMPLEX WITH MSC2317067A-1	0.175	282	201	16	297	7	251	8.866E-10	277
LOKIASV2_0185_ESMFold_hypothetical_protein	6s1i-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6s1i-assembly3.cif.gz_C Crystal Structure of DYRK1A with small molecule inhibitor	0.142	329	251	3	295	14	342	3.333E-10	277
LOKIASV2_0185_ESMFold_hypothetical_protein	1q97-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	1q97-assembly2.cif.gz_B The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	0.168	342	255	3	309	2	343	1.253E-10	277
LOKIASV2_0185_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_B ROCK 1 bound to methoxyphenyl thiazole inhibitor	0.165	299	220	9	307	66	330	1.044E-09	277
LOKIASV2_0185_ESMFold_hypothetical_protein	3w10-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3w10-assembly1.cif.gz_A Aurora kinase A complexed to pyrazole aminoquinoline I	0.146	282	214	16	297	8	259	5.740E-10	276
LOKIASV2_0185_ESMFold_hypothetical_protein	2bts-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2bts-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032	0.180	283	213	16	298	4	264	1.229E-09	276
LOKIASV2_0185_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_B Structure of the N-terminal domain of SAD	0.178	297	203	1	297	6	253	2.004E-09	276
LOKIASV2_0185_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_B Structure and Activation Mechanism of the CHK2 DNA-Damage Checkpoint Kinase	0.190	289	198	16	304	132	376	1.527E-09	276
LOKIASV2_0185_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.166	298	216	10	307	65	324	7.134E-10	276
LOKIASV2_0185_ESMFold_hypothetical_protein	6qft-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6qft-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidin 1b	0.162	296	217	5	300	1	260	9.362E-10	275
LOKIASV2_0185_ESMFold_hypothetical_protein	3unk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3unk-assembly1.cif.gz_A CDK2 in complex with inhibitor YL5-083	0.166	283	234	16	298	4	285	8.866E-10	275
LOKIASV2_0185_ESMFold_hypothetical_protein	3vw8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3vw8-assembly1.cif.gz_A Crystal structure of human c-Met kinase domain with its inhibitor	0.175	282	211	16	297	38	294	1.370E-09	275
LOKIASV2_0185_ESMFold_hypothetical_protein	4xbr-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4xbr-assembly1.cif.gz_A In cellulo Crystal Structure of PAK4 in complex with Inka	0.176	293	214	5	297	40	300	1.164E-09	275
LOKIASV2_0185_ESMFold_hypothetical_protein	4ual-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	4ual-assembly1.cif.gz_A-2 MRCK beta in complex with BDP00005290	0.155	266	209	16	281	78	325	1.527E-09	275
LOKIASV2_0185_ESMFold_hypothetical_protein	3cok-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3cok-assembly2.cif.gz_B Crystal structure of PLK4 kinase	0.169	281	183	16	296	13	233	2.116E-09	274
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly3.cif.gz_C GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.154	265	191	16	280	8	234	9.362E-10	274
LOKIASV2_0185_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_D Structure of the OSR1 kinase, a hypertension drug target	0.182	277	218	16	292	12	278	2.405E-10	274
LOKIASV2_0185_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G5018	0.183	283	210	9	291	66	323	2.932E-09	274
LOKIASV2_0185_ESMFold_hypothetical_protein	3k2l-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3k2l-assembly1.cif.gz_A Crystal Structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (DYRK2)	0.169	315	234	14	296	85	399	2.682E-10	274
LOKIASV2_0185_ESMFold_hypothetical_protein	2xnm-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2xnm-assembly1.cif.gz_A Structure of NEK2 bound to CCT	0.167	272	198	16	287	6	244	7.953E-10	273
LOKIASV2_0185_ESMFold_hypothetical_protein	3r8m-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3r8m-assembly1.cif.gz_A CDK2 in complex with inhibitor L3-3	0.195	283	219	16	298	4	276	2.359E-09	273
LOKIASV2_0185_ESMFold_hypothetical_protein	5kz8-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5kz8-assembly2.cif.gz_B Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	0.144	349	240	16	364	6	286	1.229E-09	273
LOKIASV2_0185_ESMFold_hypothetical_protein	1wbp-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1wbp-assembly1.cif.gz_A SRPK1 bound to 9mer docking motif peptide	0.141	348	253	1	295	1	348	6.060E-10	273
LOKIASV2_0185_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	0.139	430	356	8	437	1	415	5.654E-12	273
LOKIASV2_0185_ESMFold_hypothetical_protein	5he2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5he2-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224406	0.136	449	377	6	442	153	601	1.169E-12	273
LOKIASV2_0185_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent ligand at F80C	0.177	283	228	16	298	3	280	1.297E-09	272
LOKIASV2_0185_ESMFold_hypothetical_protein	3s0o-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3s0o-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-1-138	0.173	283	231	16	298	4	283	1.446E-09	272
LOKIASV2_0185_ESMFold_hypothetical_protein	6csw-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6csw-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N-methyl-N-propyl-dihydropteridine inhibitor	0.118	302	256	1	291	1	302	1.612E-09	272
LOKIASV2_0185_ESMFold_hypothetical_protein	6c2y-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6c2y-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257142	0.138	428	366	6	431	153	580	1.805E-12	272
LOKIASV2_0185_ESMFold_hypothetical_protein	3d5v-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3d5v-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain.	0.146	285	198	3	287	1	233	4.289E-09	271
LOKIASV2_0185_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactive state.	0.175	288	220	13	300	8	275	6.756E-10	271
LOKIASV2_0185_ESMFold_hypothetical_protein	4mao-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4mao-assembly1.cif.gz_A RSK2 T493M C-Terminal Kinase Domain in Complex with RMM58	0.199	285	209	16	300	8	269	1.229E-09	271
LOKIASV2_0185_ESMFold_hypothetical_protein	6una-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6una-assembly2.cif.gz_B Crystal structure of inactive p38gamma	0.184	297	228	1	297	12	292	4.618E-10	271
LOKIASV2_0185_ESMFold_hypothetical_protein	5mxx-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5mxx-assembly1.cif.gz_A Crystal structure of human SR protein kinase 1 (SRPK1) in complex with compound 1	0.139	348	254	3	298	14	361	9.885E-10	271
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly6.cif.gz_F	LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly6.cif.gz_F GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.154	265	195	16	280	7	238	1.898E-09	270
LOKIASV2_0185_ESMFold_hypothetical_protein	2jii-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2jii-assembly2.cif.gz_B Structure of vaccinia related kinase 3	0.126	314	267	1	307	13	326	8.866E-10	270
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly2.cif.gz_B GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.151	265	197	16	280	8	240	5.943E-09	269
LOKIASV2_0185_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_D Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	0.163	266	196	16	281	8	242	1.164E-09	269
LOKIASV2_0185_ESMFold_hypothetical_protein	6s1f-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6s1f-assembly1.cif.gz_A Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	0.157	278	213	20	297	18	271	1.797E-09	269
LOKIASV2_0185_ESMFold_hypothetical_protein	3e88-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3e88-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	0.156	291	226	10	300	2	270	1.898E-09	269
LOKIASV2_0185_ESMFold_hypothetical_protein	3t8o-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3t8o-assembly1.cif.gz_A Rhodopsin kinase (GRK1) L166K mutant at 2.5A resolution	0.158	363	290	6	368	149	493	1.424E-11	269
LOKIASV2_0185_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_C Structure of the OSR1 kinase, a hypertension drug target	0.164	273	214	16	288	9	265	3.923E-10	268
LOKIASV2_0185_ESMFold_hypothetical_protein	1v1k-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1v1k-assembly1.cif.gz_A CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR	0.167	283	219	16	298	4	267	4.289E-09	268
LOKIASV2_0185_ESMFold_hypothetical_protein	3f5p-assembly17.cif.gz_G	LOKIASV2_0185_ESMFold_hypothetical_protein	3f5p-assembly17.cif.gz_G Complex Structure of Insulin-like Growth Factor Receptor and 3-Cyanoquinoline Inhibitor	0.188	278	215	16	293	20	285	2.116E-09	268
LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_H-2	LOKIASV2_0185_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_H-2 ROCK2 IN COMPLEX WITH COMPOUND 12	0.169	272	191	10	281	63	293	2.116E-09	268
LOKIASV2_0185_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_G	LOKIASV2_0185_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_G CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	0.168	303	223	10	312	65	333	1.446E-09	268
LOKIASV2_0185_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3tku-assembly1.cif.gz_B MRCK beta in complex with fasudil	0.157	290	227	16	305	75	344	1.297E-09	268
LOKIASV2_0185_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_B Crystal structure of SPAK (STK39) dimer in the basal activity state	0.166	290	234	16	305	11	291	9.885E-10	267
LOKIASV2_0185_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A Structure of the N-terminal domain of SAD	0.174	294	211	16	309	12	267	5.740E-10	267
LOKIASV2_0185_ESMFold_hypothetical_protein	7b9l-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7b9l-assembly2.cif.gz_B MEK1 in complex with compound 23	0.175	295	215	6	300	19	280	8.866E-10	266
LOKIASV2_0185_ESMFold_hypothetical_protein	7b9l-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7b9l-assembly1.cif.gz_A MEK1 in complex with compound 23	0.179	295	209	6	300	27	282	1.102E-09	266
LOKIASV2_0185_ESMFold_hypothetical_protein	7p1l-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7p1l-assembly2.cif.gz_B The MARK3 Kinase Domain Bound To AA-CS-1-008	0.169	284	202	16	299	7	250	2.004E-09	266
LOKIASV2_0185_ESMFold_hypothetical_protein	7b94-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7b94-assembly1.cif.gz_A MEK1 in complex with compound 6	0.183	293	208	8	300	29	284	1.044E-09	266
LOKIASV2_0185_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	0.214	283	199	16	298	12	265	3.716E-10	266
LOKIASV2_0185_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_A Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	0.175	283	213	9	291	65	323	8.694E-09	266
LOKIASV2_0185_ESMFold_hypothetical_protein	3ncz-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	3ncz-assembly2.cif.gz_C X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor	0.195	283	209	9	291	65	325	1.581E-08	266
LOKIASV2_0185_ESMFold_hypothetical_protein	7k7l-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.136	427	367	6	431	153	579	1.906E-12	266
LOKIASV2_0185_ESMFold_hypothetical_protein	5wg5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5wg5-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG224061	0.136	434	368	6	432	149	582	1.107E-12	266
LOKIASV2_0185_ESMFold_hypothetical_protein	3efw-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3efw-assembly1.cif.gz_A Structure of AuroraA with pyridyl-pyrimidine urea inhibitor	0.143	291	203	8	298	1	238	1.272E-08	265
LOKIASV2_0185_ESMFold_hypothetical_protein	3efw-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3efw-assembly2.cif.gz_B Structure of AuroraA with pyridyl-pyrimidine urea inhibitor	0.147	283	197	16	298	8	239	1.141E-08	265
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.148	265	198	16	280	8	240	2.004E-09	265
LOKIASV2_0185_ESMFold_hypothetical_protein	4zy5-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4zy5-assembly2.cif.gz_B Crystal Structure of p21-activated kinase 1 in complex with an inhibitor compound 17	0.171	285	221	16	300	16	283	3.923E-10	265
LOKIASV2_0185_ESMFold_hypothetical_protein	6hhj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6hhj-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 24b	0.153	291	226	8	298	109	376	8.866E-10	265
LOKIASV2_0185_ESMFold_hypothetical_protein	3pvw-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3pvw-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and a selective kinase inhibitor (CMPD103A)	0.137	427	366	6	432	154	578	4.549E-12	265
LOKIASV2_0185_ESMFold_hypothetical_protein	1mry-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1mry-assembly1.cif.gz_A crystal structure of an inactive akt2 kinase domain	0.130	286	205	10	295	2	238	8.234E-09	264
LOKIASV2_0185_ESMFold_hypothetical_protein	2c47-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	2c47-assembly3.cif.gz_C Structure of casein kinase 1 gamma 2	0.155	268	215	30	297	9	264	2.630E-09	264
LOKIASV2_0185_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6s1f-assembly2.cif.gz_C Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	0.147	278	215	20	297	18	270	2.116E-09	264
LOKIASV2_0185_ESMFold_hypothetical_protein	2xh5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2xh5-assembly1.cif.gz_A Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to PKB	0.139	301	239	10	310	2	280	1.102E-09	264
LOKIASV2_0185_ESMFold_hypothetical_protein	2f49-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2f49-assembly2.cif.gz_B Crystal structure of Fus3 in complex with a Ste5 peptide	0.168	284	235	16	298	13	296	1.446E-09	264
LOKIASV2_0185_ESMFold_hypothetical_protein	3flw-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3flw-assembly1.cif.gz_A P38 kinase crystal structure in complex with pamapimod	0.165	311	253	3	306	1	311	1.124E-10	264
LOKIASV2_0185_ESMFold_hypothetical_protein	3fly-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3fly-assembly1.cif.gz_A P38 kinase crystal structure in complex with 6-(2,4-difluoro-phenoxy)-2-isopropylamino-8-methyl-8h-pyrido[2,3-d]pyrimidin-7-one	0.168	308	248	8	306	6	313	6.180E-11	264
LOKIASV2_0185_ESMFold_hypothetical_protein	5my8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5my8-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with SPHINX31	0.144	349	252	4	298	7	355	8.866E-10	264
LOKIASV2_0185_ESMFold_hypothetical_protein	3pvu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3pvu-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and a selective kinase inhibitor (CMPD101)	0.138	435	370	6	440	153	582	3.109E-12	264
LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_D Crystal Structure of Domain-Swapped OSR1 kinase domain	0.165	289	234	4	292	1	281	3.095E-09	263
LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4czt-assembly1.cif.gz_C Crystal structure of the kinase domain of CIPK23	0.212	272	196	16	287	4	253	5.740E-10	263
LOKIASV2_0185_ESMFold_hypothetical_protein	3ptg-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3ptg-assembly1.cif.gz_A Design and Synthesis of a Novel, Orally Efficacious Tri-substituted Thiophene Based JNK Inhibitor	0.158	299	246	5	297	1	299	2.043E-10	263
LOKIASV2_0185_ESMFold_hypothetical_protein	6ed6-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6ed6-assembly2.cif.gz_B Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor	0.161	298	206	10	307	60	305	1.612E-09	263
LOKIASV2_0185_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4d28-assembly2.cif.gz_C Crystal structure of the kinase domain of CIPK24/SOS2	0.208	279	200	16	294	5	257	3.644E-09	262
LOKIASV2_0185_ESMFold_hypothetical_protein	5ukm-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ukm-assembly1.cif.gz_A bovine GRK2 in complex with human Gbetagamma subunits and CCG258208 (14as)	0.127	434	373	6	433	152	585	3.466E-12	262
LOKIASV2_0185_ESMFold_hypothetical_protein	8x88-assembly3.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8x88-assembly3.cif.gz_A The Crystal Structure of TNIK from Biortus.	0.154	289	237	16	304	11	291	9.362E-10	261
LOKIASV2_0185_ESMFold_hypothetical_protein	2onl-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2onl-assembly1.cif.gz_A Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	0.177	299	245	8	306	6	304	1.644E-10	261
LOKIASV2_0185_ESMFold_hypothetical_protein	5he0-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5he0-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG215022	0.141	435	367	6	433	153	587	3.109E-12	261
LOKIASV2_0185_ESMFold_hypothetical_protein	6u2g-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6u2g-assembly1.cif.gz_A BRAF-MEK complex with AMP-PCP bound to BRAF	0.192	295	221	6	300	17	291	2.776E-09	260
LOKIASV2_0185_ESMFold_hypothetical_protein	6bxi-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6bxi-assembly2.cif.gz_B X-ray crystal structure of NDR1 kinase domain	0.159	312	244	9	299	1	312	7.532E-10	260
LOKIASV2_0185_ESMFold_hypothetical_protein	2bal-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2bal-assembly1.cif.gz_A p38alpha MAP kinase bound to pyrazoloamine	0.172	299	246	8	306	5	302	7.532E-10	260
LOKIASV2_0185_ESMFold_hypothetical_protein	4loq-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4loq-assembly3.cif.gz_C Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form with bound sulphate)	0.175	290	236	8	294	6	295	7.134E-10	260
LOKIASV2_0185_ESMFold_hypothetical_protein	5kkt-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5kkt-assembly1.cif.gz_B ROCK 1 bound to azaindole thiazole piperazine inhibitor	0.173	299	218	9	307	66	330	1.446E-09	260
LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_C Crystal Structure of Domain-Swapped OSR1 kinase domain	0.178	277	219	16	292	11	278	1.527E-09	259
LOKIASV2_0185_ESMFold_hypothetical_protein	3rcd-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3rcd-assembly1.cif.gz_A HER2 Kinase Domain Complexed with TAK-285	0.169	288	203	14	301	12	256	1.297E-09	259
LOKIASV2_0185_ESMFold_hypothetical_protein	4ark-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4ark-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MAP KINASE KINASE 1 (MEK1) IN COMPLEX WITH A SMALL MOLECULE INHIBITOR AND ADP	0.164	285	222	16	300	8	274	3.451E-09	259
LOKIASV2_0185_ESMFold_hypothetical_protein	1s9i-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	1s9i-assembly1.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 2 (MEK2)in a complex with ligand and MgATP	0.175	299	226	2	300	1	275	1.702E-09	259
LOKIASV2_0185_ESMFold_hypothetical_protein	5ukf-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	5ukf-assembly3.cif.gz_C Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	0.115	298	254	4	291	3	300	3.095E-09	259
LOKIASV2_0185_ESMFold_hypothetical_protein	5dmz-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5dmz-assembly2.cif.gz_B Structure of human Bub1 kinase domain phosphorylated at Ser969	0.164	298	235	1	298	37	318	1.370E-09	259
LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly3.cif.gz_C Crystal structure of SRPK2 in complex with compound 1	0.134	343	249	4	291	4	346	5.331E-09	259
LOKIASV2_0185_ESMFold_hypothetical_protein	3vud-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3vud-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1	0.167	310	242	5	295	2	311	2.990E-10	259
LOKIASV2_0185_ESMFold_hypothetical_protein	3vui-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3vui-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1	0.160	312	245	5	297	2	313	4.876E-10	259
LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_B Crystal Structure of Domain-Swapped OSR1 kinase domain	0.174	277	217	16	292	12	275	6.995E-09	258
LOKIASV2_0185_ESMFold_hypothetical_protein	5j5t-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	5j5t-assembly1.cif.gz_A-2 GLK co-crystal structure with aminopyrrolopyrimidine inhibitor	0.173	293	238	16	308	5	293	2.043E-10	258
LOKIASV2_0185_ESMFold_hypothetical_protein	3v5w-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3v5w-assembly1.cif.gz_A Human G Protein-Coupled Receptor Kinase 2 in Complex with Soluble Gbetagamma Subunits and Paroxetine	0.134	436	369	6	432	153	588	3.864E-12	258
LOKIASV2_0185_ESMFold_hypothetical_protein	7mf0-assembly1.cif.gz_AAA	LOKIASV2_0185_ESMFold_hypothetical_protein	7mf0-assembly1.cif.gz_AAA Co-crystal structure of PERK with inhibitor (R)-2-amino-N-cyclopropyl-5-(4-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-2-methylphenyl)nicotinamide	0.190	276	200	16	291	8	255	4.528E-09	257
LOKIASV2_0185_ESMFold_hypothetical_protein	6qho-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6qho-assembly1.cif.gz_A Dual specificity mitogen-activated protein kinase kinase 7 in complex with pyrazolopyrimidine 1a	0.157	296	217	5	300	1	258	8.234E-09	257
LOKIASV2_0185_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	1f3m-assembly1.cif.gz_C CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1	0.167	277	204	16	292	22	267	9.885E-10	257
LOKIASV2_0185_ESMFold_hypothetical_protein	2c5y-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2c5y-assembly1.cif.gz_A DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN	0.176	283	228	16	298	4	281	4.528E-09	257
LOKIASV2_0185_ESMFold_hypothetical_protein	4d9u-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4d9u-assembly1.cif.gz_A Rsk2 C-terminal Kinase Domain, (E)-tert-butyl 3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)-2-cyanoacrylate	0.204	285	208	16	300	15	276	6.060E-10	257
LOKIASV2_0185_ESMFold_hypothetical_protein	6b2e-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6b2e-assembly1.cif.gz_A Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4.	0.150	434	360	8	441	1	424	1.424E-11	257
LOKIASV2_0185_ESMFold_hypothetical_protein	3uqc-assembly1.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	3uqc-assembly1.cif.gz_C Structure of the Intracellular Kinase Homology Domain of Rv3910 at 2.2 A resolution	0.124	295	215	2	296	4	249	3.205E-08	256
LOKIASV2_0185_ESMFold_hypothetical_protein	7m0z-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7m0z-assembly1.cif.gz_B Crystal structure of the BRAF:MEK1 kinases in complex with AMPPNP and CH5126766	0.172	293	225	8	300	20	292	1.702E-09	256
LOKIASV2_0185_ESMFold_hypothetical_protein	6csw-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6csw-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N-methyl-N-propyl-dihydropteridine inhibitor	0.107	295	257	3	291	1	295	7.134E-10	256
LOKIASV2_0185_ESMFold_hypothetical_protein	5uu1-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5uu1-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to BI-D1870	0.138	303	260	5	307	3	305	7.134E-10	256
LOKIASV2_0185_ESMFold_hypothetical_protein	3lff-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3lff-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL166	0.175	299	244	8	306	5	301	3.519E-10	256
LOKIASV2_0185_ESMFold_hypothetical_protein	2hw6-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2hw6-assembly2.cif.gz_B Crystal structure of Mnk1 catalytic domain	0.187	275	179	16	290	9	229	2.875E-08	255
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.163	265	191	16	280	8	236	3.095E-09	255
LOKIASV2_0185_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B Crystal Structure of the Human Ribosomal protein S6 kinase	0.186	285	204	16	300	4	255	1.612E-09	255
LOKIASV2_0185_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_D Heterodimeric structure of ERK2 and RSK1	0.184	285	211	16	300	6	264	1.297E-09	255
LOKIASV2_0185_ESMFold_hypothetical_protein	6vxu-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6vxu-assembly2.cif.gz_B Structure of Human Vaccinia-related Kinase 1 (VRK1) bound to ACH471	0.093	301	271	4	304	1	300	4.528E-09	254
LOKIASV2_0185_ESMFold_hypothetical_protein	6ncg-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6ncg-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to pyridin-benzenesulfonamide inhibitor	0.107	298	260	3	294	1	298	4.289E-09	254
LOKIASV2_0185_ESMFold_hypothetical_protein	5wg3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5wg3-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG258748	0.129	431	372	6	433	153	583	4.308E-12	254
LOKIASV2_0185_ESMFold_hypothetical_protein	4mk0-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4mk0-assembly1.cif.gz_A Crystal structure of G protein-coupled receptor kinase 2 in complex with a a rationally designed paroxetine derivative	0.135	443	368	6	432	153	595	5.354E-12	254
LOKIASV2_0185_ESMFold_hypothetical_protein	1mrv-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1mrv-assembly1.cif.gz_A crystal structure of an inactive Akt2 kinase domain	0.126	286	199	10	295	1	229	3.384E-08	253
LOKIASV2_0185_ESMFold_hypothetical_protein	3os3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3os3-assembly1.cif.gz_A Mitogen-activated protein kinase kinase 1 (MEK1) in complex with CH4858061 and MgATP	0.198	285	202	16	300	7	259	1.205E-08	253
LOKIASV2_0185_ESMFold_hypothetical_protein	3p4k-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3p4k-assembly1.cif.gz_A The third conformation of p38a MAP kinase observed in phosphorylated p38a and in solution	0.175	299	245	8	306	6	303	3.157E-10	253
LOKIASV2_0185_ESMFold_hypothetical_protein	4yhj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4yhj-assembly1.cif.gz_A Structure and Function of the Hypertension Variant A486V of G Protein-coupled Receptor Kinase 4 (GRK4)	0.150	301	229	6	306	154	423	4.289E-09	253
LOKIASV2_0185_ESMFold_hypothetical_protein	5wg4-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5wg4-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257284	0.146	443	371	6	440	152	594	8.271E-12	253
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly1.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly1.cif.gz_D Structure of inactive kinase RIP2K(K47R)	0.147	289	229	9	297	10	278	1.023E-08	252
LOKIASV2_0185_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_A Crystal structure of murine SPAK(T243D) in complex with AMPPNP	0.174	290	224	16	305	10	281	2.359E-09	252
LOKIASV2_0185_ESMFold_hypothetical_protein	3vvh-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3vvh-assembly2.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in complex with an inhibitor and MgATP	0.175	291	223	10	300	3	273	2.932E-09	252
LOKIASV2_0185_ESMFold_hypothetical_protein	6cmm-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6cmm-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine inhibitor	0.098	305	271	4	304	1	305	2.359E-09	252
LOKIASV2_0185_ESMFold_hypothetical_protein	6cnx-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6cnx-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase 1 (VRK1) bound to an N-propynyl-N-isopentyl-dihydropteridin inhibitor	0.107	304	268	4	304	3	306	3.268E-09	252
LOKIASV2_0185_ESMFold_hypothetical_protein	3e3p-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3e3p-assembly1.cif.gz_B Glycogen synthase kinase from Leishmania major	0.150	297	252	30	326	18	314	5.149E-10	252
LOKIASV2_0185_ESMFold_hypothetical_protein	1lew-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1lew-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A	0.172	301	247	8	306	5	305	1.833E-10	252
LOKIASV2_0185_ESMFold_hypothetical_protein	5uoj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5uoj-assembly1.cif.gz_A THE STRUCTURE OF THE MAP KINASE P38 AT 2.1 ANGSTROMS RESOLUTION	0.175	304	246	8	306	5	308	2.682E-10	252
LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly2.cif.gz_B Crystal structure of SRPK2 in complex with compound 1	0.136	344	248	4	291	4	347	3.644E-09	252
LOKIASV2_0185_ESMFold_hypothetical_protein	1bl6-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1bl6-assembly1.cif.gz_A THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995	0.170	315	251	3	306	1	315	1.397E-10	252
LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly5.cif.gz_E	LOKIASV2_0185_ESMFold_hypothetical_protein	7qwk-assembly5.cif.gz_E GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	0.155	265	185	16	280	7	226	9.180E-09	251
LOKIASV2_0185_ESMFold_hypothetical_protein	6nzp-assembly3.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6nzp-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE	0.153	277	211	16	292	10	259	1.797E-09	251
LOKIASV2_0185_ESMFold_hypothetical_protein	6ac9-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6ac9-assembly4.cif.gz_D Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP	0.105	301	269	4	304	1	301	7.799E-09	251
LOKIASV2_0185_ESMFold_hypothetical_protein	6cmm-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6cmm-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine inhibitor	0.102	298	258	4	291	1	298	4.528E-09	251
LOKIASV2_0185_ESMFold_hypothetical_protein	3o8p-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3o8p-assembly1.cif.gz_A Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding	0.181	299	244	8	306	5	303	8.866E-10	251
LOKIASV2_0185_ESMFold_hypothetical_protein	2y8o-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2y8o-assembly1.cif.gz_A Crystal structure of human p38alpha complexed with a MAPK docking peptide	0.181	299	244	8	306	6	304	3.333E-10	251
LOKIASV2_0185_ESMFold_hypothetical_protein	6cqh-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6cqh-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor	0.100	301	270	4	304	3	303	8.234E-09	250
LOKIASV2_0185_ESMFold_hypothetical_protein	2okr-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	2okr-assembly2.cif.gz_D Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer	0.167	299	247	8	306	5	302	9.362E-10	250
LOKIASV2_0185_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_A Crystal structure of SPAK (STK39) dimer in the basal activity state	0.182	287	224	16	302	11	285	3.451E-09	249
LOKIASV2_0185_ESMFold_hypothetical_protein	6ac9-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6ac9-assembly3.cif.gz_C Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP	0.101	302	269	5	304	1	302	2.004E-09	249
LOKIASV2_0185_ESMFold_hypothetical_protein	3vuh-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3vuh-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M3 in MAP kinase JNK1	0.155	312	247	5	297	2	313	6.399E-10	249
LOKIASV2_0185_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_A Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor	0.177	295	210	9	303	62	317	1.965E-08	249
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly4.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly4.cif.gz_C Structure of inactive kinase RIP2K(K47R)	0.141	289	224	9	297	10	271	1.762E-08	248
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly2.cif.gz_B Structure of inactive kinase RIP2K(K47R)	0.143	289	226	9	297	10	274	8.694E-09	248
LOKIASV2_0185_ESMFold_hypothetical_protein	6bru-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6bru-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a (S)-2-phenylaminopteridinone inhibitor	0.108	301	263	4	304	1	296	1.205E-08	248
LOKIASV2_0185_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	0.134	286	235	10	295	1	272	3.451E-09	248
LOKIASV2_0185_ESMFold_hypothetical_protein	3psc-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3psc-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits	0.127	429	373	6	434	154	581	3.789E-11	248
LOKIASV2_0185_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A Crystal Structure of Human Serine Threonine Kinase-10 (LOK) Bound to GW830263A	0.170	285	211	16	300	21	275	9.693E-09	247
LOKIASV2_0185_ESMFold_hypothetical_protein	6btw-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6btw-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a phenyl-pteridinone inhibitor	0.102	290	258	4	291	1	290	1.141E-08	247
LOKIASV2_0185_ESMFold_hypothetical_protein	6bru-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6bru-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a (S)-2-phenylaminopteridinone inhibitor	0.112	306	267	3	304	1	306	1.141E-08	247
LOKIASV2_0185_ESMFold_hypothetical_protein	3zsi-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3zsi-assembly1.cif.gz_A X-ray structure of p38alpha bound to VX-745	0.177	299	237	8	306	4	292	1.527E-09	247
LOKIASV2_0185_ESMFold_hypothetical_protein	6sou-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6sou-assembly1.cif.gz_A Fragment N13565a in complex with MAP kinase p38-alpha	0.162	315	253	8	310	5	319	1.644E-10	247
LOKIASV2_0185_ESMFold_hypothetical_protein	3byv-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3byv-assembly1.cif.gz_A Crystal structure of Toxoplasma gondii specific rhoptry antigen kinase domain	0.098	305	266	2	297	36	340	3.095E-09	246
LOKIASV2_0185_ESMFold_hypothetical_protein	5r9q-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5r9q-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N07422b in complex with MAP kinase p38-alpha	0.174	319	249	8	310	5	323	3.157E-10	246
LOKIASV2_0185_ESMFold_hypothetical_protein	4lv8-assembly2.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4lv8-assembly2.cif.gz_A Murine IRGa6 bound to Toxoplasma ROP5C, a pseudokinase GDI	0.139	316	252	4	297	42	357	2.776E-09	246
LOKIASV2_0185_ESMFold_hypothetical_protein	7dts-assembly1.cif.gz_b	LOKIASV2_0185_ESMFold_hypothetical_protein	7dts-assembly1.cif.gz_b Crystal structure of RNase L in complex with AC40357	0.152	287	191	9	295	324	549	8.694E-09	246
LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly3.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ng3-assembly3.cif.gz_A Structure of inactive kinase RIP2K(K47R)	0.144	278	229	20	297	15	283	2.191E-08	245
LOKIASV2_0185_ESMFold_hypothetical_protein	6vxu-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	6vxu-assembly3.cif.gz_C Structure of Human Vaccinia-related Kinase 1 (VRK1) bound to ACH471	0.109	304	267	4	304	3	306	1.272E-08	245
LOKIASV2_0185_ESMFold_hypothetical_protein	6cfm-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6cfm-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a propynyl-pteridinone inhibitor	0.099	308	271	3	304	1	308	6.995E-09	245
LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_C Crystal Structure of ROCK 1 bound to YB-15-QD37	0.185	295	206	9	303	65	318	2.313E-08	245
LOKIASV2_0185_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_B ROCK 1 bound to a pyridine thiazole inhibitor	0.179	299	217	9	307	66	330	3.847E-09	245
LOKIASV2_0185_ESMFold_hypothetical_protein	6s9w-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6s9w-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a	0.163	290	221	9	298	113	377	3.095E-09	245
LOKIASV2_0185_ESMFold_hypothetical_protein	5r96-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5r96-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL095 in complex with MAP kinase p38-alpha	0.175	309	246	8	306	5	313	3.157E-10	244
LOKIASV2_0185_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_B Crystal structure of STING CTD in complex with TBK1	0.125	365	282	7	329	2	366	1.557E-10	244
LOKIASV2_0185_ESMFold_hypothetical_protein	8q1z-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8q1z-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to JA-296	0.111	295	256	4	292	1	295	1.272E-08	243
LOKIASV2_0185_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_A Heterodimeric structure of ERK2 and RSK1	0.170	285	214	16	300	6	264	3.451E-09	243
LOKIASV2_0185_ESMFold_hypothetical_protein	5n65-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5n65-assembly1.cif.gz_A Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9h	0.172	299	243	8	306	5	299	1.229E-09	243
LOKIASV2_0185_ESMFold_hypothetical_protein	6m11-assembly1.cif.gz_b	LOKIASV2_0185_ESMFold_hypothetical_protein	6m11-assembly1.cif.gz_b Crystal structure of Rnase L in complex with Sunitinib	0.153	264	182	16	279	334	549	1.762E-08	243
LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_A Crystal Structure of Domain-Swapped OSR1 kinase domain	0.176	277	218	16	292	12	276	3.644E-09	242
LOKIASV2_0185_ESMFold_hypothetical_protein	3ocg-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3ocg-assembly1.cif.gz_A P38 Alpha kinase complexed with a 5-amino-pyrazole based inhibitor	0.181	299	242	8	306	6	302	1.446E-09	242
LOKIASV2_0185_ESMFold_hypothetical_protein	3hv5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3hv5-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL24	0.186	300	243	8	306	6	305	7.953E-10	242
LOKIASV2_0185_ESMFold_hypothetical_protein	5r90-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5r90-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11145a in complex with MAP kinase p38-alpha	0.178	308	249	3	306	1	308	3.519E-10	242
LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly1.cif.gz_A Crystal structure of SRPK2 in complex with compound 1	0.128	347	250	4	291	4	350	1.023E-08	242
LOKIASV2_0185_ESMFold_hypothetical_protein	5he1-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5he1-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG224062	0.135	438	375	6	440	154	591	4.973E-11	242
LOKIASV2_0185_ESMFold_hypothetical_protein	3op5-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	3op5-assembly4.cif.gz_D Human vaccinia-related kinase 1	0.103	298	265	7	304	2	297	1.497E-08	241
LOKIASV2_0185_ESMFold_hypothetical_protein	1zz2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1zz2-assembly1.cif.gz_A Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes	0.178	299	245	8	306	5	303	1.702E-09	241
LOKIASV2_0185_ESMFold_hypothetical_protein	3uvq-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3uvq-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative	0.169	287	238	8	294	5	291	3.095E-09	240
LOKIASV2_0185_ESMFold_hypothetical_protein	4r3c-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4r3c-assembly1.cif.gz_A Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate	0.184	293	237	3	295	1	291	1.527E-09	240
LOKIASV2_0185_ESMFold_hypothetical_protein	8bzp-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8bzp-assembly1.cif.gz_A JNK3 (Mitogen-activated protein kinase 10) in Complex with Compound 23 bearing a C(sp3)F2Br moiety	0.182	310	239	5	297	1	310	1.797E-09	240
LOKIASV2_0185_ESMFold_hypothetical_protein	5he3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5he3-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224411	0.140	435	371	6	437	153	587	2.590E-11	240
LOKIASV2_0185_ESMFold_hypothetical_protein	8wf4-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	8wf4-assembly2.cif.gz_B The Crystal Structure of RSK1 from Biortus.	0.188	285	209	16	300	4	261	6.625E-09	239
LOKIASV2_0185_ESMFold_hypothetical_protein	6cnx-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	6cnx-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase 1 (VRK1) bound to an N-propynyl-N-isopentyl-dihydropteridin inhibitor	0.112	307	266	5	304	1	307	2.075E-08	239
LOKIASV2_0185_ESMFold_hypothetical_protein	1ian-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1ian-assembly1.cif.gz_A HUMAN P38 MAP KINASE INHIBITOR COMPLEX	0.170	302	243	5	306	1	294	1.898E-09	239
LOKIASV2_0185_ESMFold_hypothetical_protein	7z9t-assembly1.cif.gz_AAA	LOKIASV2_0185_ESMFold_hypothetical_protein	7z9t-assembly1.cif.gz_AAA Crystal structure of p38alpha C162S in complex with ATPgS and CAS 2094667-81-7 (in catalytic site, Y35 out), P 1 21 1	0.188	310	242	8	306	5	314	4.618E-10	239
LOKIASV2_0185_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_A Structure and Activation Mechanism of the CHK2 DNA-Damage Checkpoint Kinase	0.192	286	210	13	298	130	390	6.275E-09	239
LOKIASV2_0185_ESMFold_hypothetical_protein	4pnk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4pnk-assembly1.cif.gz_A G protein-coupled receptor kinase 2 in complex with GSK180736A	0.133	437	368	7	432	154	590	7.682E-11	239
LOKIASV2_0185_ESMFold_hypothetical_protein	6u7c-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6u7c-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG258747	0.144	441	364	6	431	153	593	4.973E-11	239
LOKIASV2_0185_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_A Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	0.153	291	202	16	306	3	242	5.943E-09	238
LOKIASV2_0185_ESMFold_hypothetical_protein	3e3p-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3e3p-assembly1.cif.gz_A Glycogen synthase kinase from Leishmania major	0.145	281	224	31	293	19	299	1.205E-08	238
LOKIASV2_0185_ESMFold_hypothetical_protein	7mt9-assembly1.cif.gz_G	LOKIASV2_0185_ESMFold_hypothetical_protein	7mt9-assembly1.cif.gz_G Rhodopsin kinase (GRK1) in complex with rhodopsin	0.145	351	274	16	366	25	346	2.490E-09	238
LOKIASV2_0185_ESMFold_hypothetical_protein	5ekn-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ekn-assembly1.cif.gz_A Crystal structure of MAPK13 complex with inhibitor	0.172	293	239	5	297	5	294	9.885E-10	237
LOKIASV2_0185_ESMFold_hypothetical_protein	6hwv-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6hwv-assembly1.cif.gz_A Crystal structure of p38alpha in complex with a photoswitchable 2-Azoimidazol-based Inhibitor (compound 3)	0.181	299	243	8	306	5	302	2.490E-09	237
LOKIASV2_0185_ESMFold_hypothetical_protein	3fsk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3fsk-assembly1.cif.gz_A P38 kinase crystal structure in complex with RO6257	0.180	304	244	8	306	5	308	9.885E-10	237
LOKIASV2_0185_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_B-2	LOKIASV2_0185_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_B-2 Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor	0.193	297	223	9	305	64	340	1.023E-08	237
LOKIASV2_0185_ESMFold_hypothetical_protein	3uzs-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3uzs-assembly1.cif.gz_A Structure of the C13.28 RNA Aptamer Bound to the G Protein-Coupled Receptor Kinase 2-Heterotrimeric G Protein Beta 1 and Gamma 2 Subunit Complex	0.135	430	363	6	435	154	574	2.590E-11	237
LOKIASV2_0185_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_A Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	0.158	278	201	16	293	3	242	6.995E-09	236
LOKIASV2_0185_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_B Crystal structure of murine SPAK(T243D) in complex with AMPPNP	0.166	292	226	16	307	10	281	7.386E-09	236
LOKIASV2_0185_ESMFold_hypothetical_protein	2ghl-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2ghl-assembly1.cif.gz_A Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743	0.175	299	243	8	306	5	300	2.359E-09	236
LOKIASV2_0185_ESMFold_hypothetical_protein	3lhj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3lhj-assembly1.cif.gz_A Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridinone Inhibitor.	0.177	303	245	8	306	5	307	1.702E-09	236
LOKIASV2_0185_ESMFold_hypothetical_protein	5wng-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5wng-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	0.160	299	202	9	307	66	307	9.180E-09	236
LOKIASV2_0185_ESMFold_hypothetical_protein	6hhf-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6hhf-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor Borussertib	0.121	289	205	10	298	104	337	3.772E-08	236
LOKIASV2_0185_ESMFold_hypothetical_protein	8gds-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	8gds-assembly2.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH 4-(4-(2-(2,3-DIHYDRO-1H- INDOL-1-YL)-2-OXOETHYL)PHENYL)-1(2H)-PHTHALAZINONE	0.171	281	214	10	290	64	322	1.343E-08	236
LOKIASV2_0185_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5wvd-assembly1.cif.gz_B Structure of Mnk1 in complex with DS12881479	0.189	274	162	16	289	8	208	9.002E-08	235
LOKIASV2_0185_ESMFold_hypothetical_protein	8p4z-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	8p4z-assembly2.cif.gz_B Crystal structure of the human CDK7 kinase domain in complex with LDC4297	0.188	286	214	16	301	4	268	3.772E-08	235
LOKIASV2_0185_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	0.182	288	218	13	300	9	276	2.630E-09	235
LOKIASV2_0185_ESMFold_hypothetical_protein	5o90-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5o90-assembly1.cif.gz_A Crystal structure of a P38alpha T185G mutant in complex with TAB1 peptide.	0.177	299	239	8	306	5	295	3.451E-09	235
LOKIASV2_0185_ESMFold_hypothetical_protein	4h39-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4h39-assembly1.cif.gz_A Crystal Structure of JNK3 in Complex with JIP1 Peptide	0.167	296	241	8	297	5	300	3.644E-09	235
LOKIASV2_0185_ESMFold_hypothetical_protein	2w1z-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2w1z-assembly2.cif.gz_B ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	0.124	304	257	9	302	48	351	1.861E-08	235
LOKIASV2_0185_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP	0.152	298	226	1	298	9	276	4.062E-09	234
LOKIASV2_0185_ESMFold_hypothetical_protein	5r9w-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5r9w-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13598a in complex with MAP kinase p38-alpha	0.181	318	243	8	305	5	322	6.399E-10	234
LOKIASV2_0185_ESMFold_hypothetical_protein	3hdm-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3hdm-assembly1.cif.gz_A Crystal structure of serum and glucocorticoid-regulated kinase 1 in complex with compound 1	0.159	299	225	2	300	1	268	5.628E-09	232
LOKIASV2_0185_ESMFold_hypothetical_protein	6bp0-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6bp0-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase 1 bound to (R)-2-phenylaminopteridinone inhibitor	0.095	301	270	4	304	1	299	4.441E-08	232
LOKIASV2_0185_ESMFold_hypothetical_protein	7s26-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	7s26-assembly2.cif.gz_C ROCK1 IN COMPLEX WITH LIGAND G5018	0.174	283	205	9	291	63	311	6.859E-08	232
LOKIASV2_0185_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2 Crystal structure of HPK1 in complex an inhibitor G1858	0.176	286	210	13	298	10	265	2.579E-08	231
LOKIASV2_0185_ESMFold_hypothetical_protein	6dd4-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6dd4-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	0.115	297	256	4	300	1	290	5.943E-09	231
LOKIASV2_0185_ESMFold_hypothetical_protein	3uvr-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3uvr-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with KM064	0.180	299	240	8	306	5	298	2.359E-09	231
LOKIASV2_0185_ESMFold_hypothetical_protein	8aco-assembly1.cif.gz_AAA	LOKIASV2_0185_ESMFold_hypothetical_protein	8aco-assembly1.cif.gz_AAA Crystal structure of WT p38alpha	0.170	299	244	8	306	6	300	2.359E-09	231
LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	5myv-assembly4.cif.gz_D Crystal structure of SRPK2 in complex with compound 1	0.129	346	250	4	291	4	349	3.772E-08	231
LOKIASV2_0185_ESMFold_hypothetical_protein	5yt3-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	5yt3-assembly2.cif.gz_D Structure of the Human Mitogen-Activated Protein Kinase Kinase 1 S218D and S222D mutant	0.178	291	219	10	300	25	292	3.268E-09	230
LOKIASV2_0185_ESMFold_hypothetical_protein	2v62-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	2v62-assembly2.cif.gz_B Structure of vaccinia-related kinase 2	0.105	294	258	4	292	1	294	4.206E-08	230
LOKIASV2_0185_ESMFold_hypothetical_protein	6ycu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6ycu-assembly1.cif.gz_A Fragment KCL_K777 in complex with MAP kinase p38-alpha	0.177	303	245	8	306	4	306	4.781E-09	230
LOKIASV2_0185_ESMFold_hypothetical_protein	7dsy-assembly1.cif.gz_b	LOKIASV2_0185_ESMFold_hypothetical_protein	7dsy-assembly1.cif.gz_b Crystal Structure of RNase L in complex with KM05073	0.150	287	191	9	295	320	545	4.441E-08	230
LOKIASV2_0185_ESMFold_hypothetical_protein	5uvf-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	5uvf-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to BI-D1870	0.110	290	235	7	296	4	268	6.995E-09	229
LOKIASV2_0185_ESMFold_hypothetical_protein	8x5l-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8x5l-assembly1.cif.gz_A The Crystal Structure of PRKACA from Biortus.	0.157	287	223	10	296	23	288	1.081E-08	229
LOKIASV2_0185_ESMFold_hypothetical_protein	3gcp-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3gcp-assembly1.cif.gz_A Human P38 MAP Kinase in Complex with SB203580	0.178	299	244	8	306	6	303	4.781E-09	229
LOKIASV2_0185_ESMFold_hypothetical_protein	7pvu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7pvu-assembly1.cif.gz_A Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1	0.181	299	243	8	306	5	302	1.797E-09	229
LOKIASV2_0185_ESMFold_hypothetical_protein	6anl-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6anl-assembly1.cif.gz_A Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[1,2-b]pyridazine-based p38 MAP Kinase Inhibitors	0.175	299	246	8	306	6	304	2.776E-09	229
LOKIASV2_0185_ESMFold_hypothetical_protein	3bv3-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3bv3-assembly1.cif.gz_A Morpholino pyrrolotriazine P38 Alpha Map Kinase inhibitor compound 2	0.152	292	244	16	304	20	311	6.275E-09	229
LOKIASV2_0185_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_B Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	0.153	276	202	16	291	4	243	1.141E-08	228
LOKIASV2_0185_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	0.166	286	214	13	298	11	268	9.693E-09	228
LOKIASV2_0185_ESMFold_hypothetical_protein	1kv1-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1kv1-assembly1.cif.gz_A p38 MAP Kinase in Complex with Inhibitor 1	0.185	302	241	5	306	1	297	3.644E-09	228
LOKIASV2_0185_ESMFold_hypothetical_protein	3bv2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3bv2-assembly1.cif.gz_A Morpholino pyrrolotriazine P38 Alpha map kinase inhibitor compound 30	0.183	300	243	8	306	5	304	2.776E-09	228
LOKIASV2_0185_ESMFold_hypothetical_protein	5etf-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5etf-assembly1.cif.gz_A Structure of dead kinase MAPK14 with bound the KIM domain of MKK6	0.174	299	245	8	306	6	303	3.644E-09	228
LOKIASV2_0185_ESMFold_hypothetical_protein	7elw-assembly1.cif.gz_b	LOKIASV2_0185_ESMFold_hypothetical_protein	7elw-assembly1.cif.gz_b Crystal structure of RNase L in complex with Myricetin	0.155	269	180	9	277	320	533	3.983E-08	228
LOKIASV2_0185_ESMFold_hypothetical_protein	7mfd-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7mfd-assembly1.cif.gz_B Autoinhibited BRAF:(14-3-3)2:MEK complex with the BRAF RBD resolved	0.174	300	225	1	300	3	275	1.669E-08	227
LOKIASV2_0185_ESMFold_hypothetical_protein	3q5z-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3q5z-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain	0.143	297	250	4	300	42	334	3.772E-08	227
LOKIASV2_0185_ESMFold_hypothetical_protein	3beg-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3beg-assembly1.cif.gz_A Crystal structure of SR protein kinase 1 complexed to its substrate ASF/SF2	0.139	348	254	3	298	1	348	3.772E-08	227
LOKIASV2_0185_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G5018	0.169	283	205	9	291	65	312	4.951E-08	227
LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_B Crystal Structure of ROCK 1 bound to YB-15-QD37	0.183	299	211	9	307	65	323	4.441E-08	227
LOKIASV2_0185_ESMFold_hypothetical_protein	4e5a-assembly1.cif.gz_X	LOKIASV2_0185_ESMFold_hypothetical_protein	4e5a-assembly1.cif.gz_X The W197A mutant of p38a MAP kinase	0.183	304	242	3	306	1	297	2.359E-09	226
LOKIASV2_0185_ESMFold_hypothetical_protein	3huc-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3huc-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL40	0.180	304	248	3	306	1	303	3.268E-09	226
LOKIASV2_0185_ESMFold_hypothetical_protein	1ywr-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1ywr-assembly1.cif.gz_A Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor	0.176	300	246	8	306	5	304	2.932E-09	226
LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G4998	0.178	272	198	9	280	63	304	3.205E-08	226
LOKIASV2_0185_ESMFold_hypothetical_protein	4hys-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4hys-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-(4-Indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan	0.166	293	243	5	297	1	292	8.234E-09	225
LOKIASV2_0185_ESMFold_hypothetical_protein	6so2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6so2-assembly1.cif.gz_A Fragment N13460a in complex with MAP kinase p38-alpha	0.172	311	251	3	306	1	311	1.797E-09	225
LOKIASV2_0185_ESMFold_hypothetical_protein	6y7y-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6y7y-assembly1.cif.gz_A Fragments KCL_771 and KCL_802 in complex with MAP kinase p38-alpha	0.178	299	245	8	306	4	302	1.081E-08	224
LOKIASV2_0185_ESMFold_hypothetical_protein	6sp9-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6sp9-assembly1.cif.gz_A Fragment KCL802 in complex with MAP kinase p38-alpha	0.174	303	246	8	306	5	307	1.669E-08	224
LOKIASV2_0185_ESMFold_hypothetical_protein	4o2z-assembly1.cif.gz_A-2	LOKIASV2_0185_ESMFold_hypothetical_protein	4o2z-assembly1.cif.gz_A-2 Crystal Structure of MPK3 from Leishmania donovani, LdBPK_100540 in the presence of NVP-BBT594	0.159	311	245	16	307	35	345	5.628E-09	224
LOKIASV2_0185_ESMFold_hypothetical_protein	7m74-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7m74-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	0.140	428	301	10	437	1	351	1.164E-09	224
LOKIASV2_0185_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 11	0.169	286	227	16	301	10	283	9.693E-09	223
LOKIASV2_0185_ESMFold_hypothetical_protein	2gtn-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2gtn-assembly1.cif.gz_A Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717	0.177	299	245	8	306	5	303	7.386E-09	223
LOKIASV2_0185_ESMFold_hypothetical_protein	3q60-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3q60-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain bound to ATP	0.140	290	246	14	300	57	346	3.983E-08	223
LOKIASV2_0185_ESMFold_hypothetical_protein	4o1p-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4o1p-assembly2.cif.gz_C Crystal Structure of RNase L in complex with 2-5A and AMP-PNP	0.137	269	186	9	277	322	538	1.927E-07	223
LOKIASV2_0185_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	0.160	278	197	16	293	5	239	3.384E-08	222
LOKIASV2_0185_ESMFold_hypothetical_protein	6sov-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6sov-assembly1.cif.gz_A Fragments KCL_615 and KCL_802 in complex with MAP kinase p38-alpha	0.175	301	246	8	306	4	304	2.075E-08	222
LOKIASV2_0185_ESMFold_hypothetical_protein	5r94-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5r94-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL081 in complex with MAP kinase p38-alpha	0.163	307	249	8	306	6	312	2.630E-09	222
LOKIASV2_0185_ESMFold_hypothetical_protein	6y80-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6y80-assembly1.cif.gz_A Fragment KCL_916 in complex with MAP kinase p38-alpha	0.177	302	245	8	306	5	306	1.418E-08	222
LOKIASV2_0185_ESMFold_hypothetical_protein	6hhh-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6hhh-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 31	0.121	289	211	10	298	110	350	5.519E-08	222
LOKIASV2_0185_ESMFold_hypothetical_protein	4aa5-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4aa5-assembly1.cif.gz_A P38ALPHA MAP KINASE BOUND TO CMPD 33	0.190	302	241	8	306	5	306	9.180E-09	221
LOKIASV2_0185_ESMFold_hypothetical_protein	3dzo-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3dzo-assembly1.cif.gz_A Crystal structure of a rhoptry kinase from toxoplasma gondii	0.119	299	260	5	300	47	345	4.951E-08	221
LOKIASV2_0185_ESMFold_hypothetical_protein	4izy-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4izy-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(4-Methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}-cyclohexan	0.165	293	244	5	297	1	293	1.205E-08	220
LOKIASV2_0185_ESMFold_hypothetical_protein	6y7w-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6y7w-assembly1.cif.gz_A Fragment KCL_1337 in complex with MAP kinase p38-alpha	0.172	300	247	8	306	4	303	1.861E-08	220
LOKIASV2_0185_ESMFold_hypothetical_protein	6m13-assembly1.cif.gz_a	LOKIASV2_0185_ESMFold_hypothetical_protein	6m13-assembly1.cif.gz_a Crystal structure of Rnase L in complex with Toceranib	0.150	297	190	9	305	328	552	2.723E-08	220
LOKIASV2_0185_ESMFold_hypothetical_protein	8acm-assembly1.cif.gz_AAA	LOKIASV2_0185_ESMFold_hypothetical_protein	8acm-assembly1.cif.gz_AAA Crystal structure of WT p38alpha	0.157	299	250	8	306	6	302	9.693E-09	219
LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_C ROCK1 IN COMPLEX WITH LIGAND G4998	0.167	299	205	9	307	58	304	2.579E-08	219
LOKIASV2_0185_ESMFold_hypothetical_protein	3k3i-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3k3i-assembly1.cif.gz_A p38alpha bound to novel DGF-out compound PF-00215955	0.164	299	245	8	306	5	298	1.023E-08	218
LOKIASV2_0185_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	0.175	283	214	16	298	18	277	1.581E-08	217
LOKIASV2_0185_ESMFold_hypothetical_protein	5xzw-assembly3.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5xzw-assembly3.cif.gz_A Crystal structure of Rad53 1-466	0.190	273	185	16	288	146	374	3.699E-07	216
LOKIASV2_0185_ESMFold_hypothetical_protein	2w1z-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2w1z-assembly1.cif.gz_A ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	0.120	291	253	14	302	58	348	3.573E-08	215
LOKIASV2_0185_ESMFold_hypothetical_protein	7dts-assembly1.cif.gz_a	LOKIASV2_0185_ESMFold_hypothetical_protein	7dts-assembly1.cif.gz_a Crystal structure of RNase L in complex with AC40357	0.155	305	188	1	305	319	542	1.205E-08	215
LOKIASV2_0185_ESMFold_hypothetical_protein	6m11-assembly1.cif.gz_a	LOKIASV2_0185_ESMFold_hypothetical_protein	6m11-assembly1.cif.gz_a Crystal structure of Rnase L in complex with Sunitinib	0.162	297	185	9	305	330	551	2.875E-08	215
LOKIASV2_0185_ESMFold_hypothetical_protein	6m13-assembly1.cif.gz_b	LOKIASV2_0185_ESMFold_hypothetical_protein	6m13-assembly1.cif.gz_b Crystal structure of Rnase L in complex with Toceranib	0.159	291	181	8	298	329	544	4.689E-08	215
LOKIASV2_0185_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A HPK1 IN COMPLEX WITH COMPOUND 11	0.178	285	215	16	300	11	272	3.205E-08	214
LOKIASV2_0185_ESMFold_hypothetical_protein	6npn-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6npn-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine-3-hydroxyindazole inhibitor	0.093	300	268	5	304	1	296	1.927E-07	214
LOKIASV2_0185_ESMFold_hypothetical_protein	4lv5-assembly2.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4lv5-assembly2.cif.gz_A Murine IRGa6 bound to Toxoplasma ROP5B, a pseudokinase GDI	0.141	292	241	14	295	58	349	3.772E-08	214
LOKIASV2_0185_ESMFold_hypothetical_protein	3new-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3new-assembly1.cif.gz_A p38-alpha complexed with Compound 10	0.175	296	241	8	303	5	297	2.442E-08	213
LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_D Crystal Structure of ROCK 1 bound to YB-15-QD37	0.180	299	212	9	307	65	323	1.581E-08	213
LOKIASV2_0185_ESMFold_hypothetical_protein	4l8m-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4l8m-assembly1.cif.gz_A Human p38 MAP kinase in complex with a Dibenzoxepinone	0.170	301	247	8	306	5	305	5.827E-08	212
LOKIASV2_0185_ESMFold_hypothetical_protein	4aa0-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4aa0-assembly1.cif.gz_A P38ALPHA MAP KINASE BOUND TO CMPD 2	0.184	303	246	8	310	5	306	1.023E-08	211
LOKIASV2_0185_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	0.172	294	219	13	306	9	273	1.965E-08	210
LOKIASV2_0185_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	0.189	292	224	16	307	7	283	3.035E-08	210
LOKIASV2_0185_ESMFold_hypothetical_protein	5ukl-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	5ukl-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG222886 (14bd)	0.127	449	381	6	442	152	600	6.399E-10	210
LOKIASV2_0185_ESMFold_hypothetical_protein	7elw-assembly1.cif.gz_a	LOKIASV2_0185_ESMFold_hypothetical_protein	7elw-assembly1.cif.gz_a Crystal structure of RNase L in complex with Myricetin	0.166	290	179	16	305	330	545	4.441E-08	210
LOKIASV2_0185_ESMFold_hypothetical_protein	6s9x-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6s9x-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 15c	0.139	291	210	8	298	105	349	1.637E-07	209
LOKIASV2_0185_ESMFold_hypothetical_protein	6m12-assembly1.cif.gz_a	LOKIASV2_0185_ESMFold_hypothetical_protein	6m12-assembly1.cif.gz_a Crystal Structure of Rnase L in complex with SU11652	0.168	290	181	16	305	332	550	3.983E-08	209
LOKIASV2_0185_ESMFold_hypothetical_protein	5uvf-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	5uvf-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to BI-D1870	0.104	298	259	7	304	2	291	3.318E-07	208
LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G4998	0.167	295	198	9	303	64	302	4.354E-07	208
LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_A Crystal Structure of ROCK 1 bound to YB-15-QD37	0.183	299	211	9	307	65	323	3.205E-08	208
LOKIASV2_0185_ESMFold_hypothetical_protein	7byk-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	7byk-assembly1.cif.gz_A Crystal structure of the Legionella pneumophila LegK7 effector kinase	0.164	263	215	30	292	173	430	6.153E-08	208
LOKIASV2_0185_ESMFold_hypothetical_protein	6m12-assembly1.cif.gz_b	LOKIASV2_0185_ESMFold_hypothetical_protein	6m12-assembly1.cif.gz_b Crystal Structure of Rnase L in complex with SU11652	0.159	283	175	16	298	335	543	5.519E-08	208
LOKIASV2_0185_ESMFold_hypothetical_protein	4o1p-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4o1p-assembly1.cif.gz_B Crystal Structure of RNase L in complex with 2-5A and AMP-PNP	0.155	297	187	9	305	322	543	1.181E-07	206
LOKIASV2_0185_ESMFold_hypothetical_protein	3aln-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3aln-assembly1.cif.gz_A Crystal Structure of human non-phosphorylated MKK4 kinase domain complexed with AMP-PNP	0.132	306	231	1	306	4	270	1.695E-06	205
LOKIASV2_0185_ESMFold_hypothetical_protein	4oth-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4oth-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Ro-31-8220	0.136	290	214	8	297	3	251	2.395E-07	205
LOKIASV2_0185_ESMFold_hypothetical_protein	4e8a-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4e8a-assembly1.cif.gz_A The crystal structure of p38a MAP kinase in complex with PIA24	0.152	293	239	3	295	1	283	1.861E-08	205
LOKIASV2_0185_ESMFold_hypothetical_protein	2bak-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2bak-assembly1.cif.gz_A p38alpha MAP kinase bound to MPAQ	0.189	299	238	8	306	5	299	2.075E-08	205
LOKIASV2_0185_ESMFold_hypothetical_protein	4oti-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4oti-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Tofacitinib	0.144	290	211	8	297	3	249	3.143E-07	204
LOKIASV2_0185_ESMFold_hypothetical_protein	2v62-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2v62-assembly1.cif.gz_A Structure of vaccinia-related kinase 2	0.092	293	262	4	292	1	293	3.143E-07	203
LOKIASV2_0185_ESMFold_hypothetical_protein	1yw2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1yw2-assembly1.cif.gz_A Mutated Mus Musculus P38 Kinase (mP38)	0.173	306	251	3	306	1	306	5.827E-08	203
LOKIASV2_0185_ESMFold_hypothetical_protein	1kv2-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	1kv2-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with BIRB 796	0.168	302	241	5	306	1	291	3.035E-08	201
LOKIASV2_0185_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 7-(1-methyl-1H-pyrazol-4-yl)-N-[4-(1-methylpiperidin-4-yl)phenyl]quinazolin-2-amine	0.176	285	216	16	300	11	273	9.002E-08	199
LOKIASV2_0185_ESMFold_hypothetical_protein	2baj-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2baj-assembly1.cif.gz_A p38alpha bound to pyrazolourea	0.180	285	226	16	300	23	299	2.579E-08	199
LOKIASV2_0185_ESMFold_hypothetical_protein	4o1p-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	4o1p-assembly2.cif.gz_D Crystal Structure of RNase L in complex with 2-5A and AMP-PNP	0.152	294	186	9	302	322	541	2.528E-07	199
LOKIASV2_0185_ESMFold_hypothetical_protein	4awi-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4awi-assembly1.cif.gz_A Human Jnk1alpha kinase with 4-phenyl-7-azaindole IKK2 inhibitor.	0.143	350	250	5	297	1	350	1.141E-08	197
LOKIASV2_0185_ESMFold_hypothetical_protein	7byk-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	7byk-assembly2.cif.gz_B Crystal structure of the Legionella pneumophila LegK7 effector kinase	0.159	262	219	40	300	187	448	1.468E-07	197
LOKIASV2_0185_ESMFold_hypothetical_protein	4o1o-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4o1o-assembly1.cif.gz_A Crystal Structure of RNase L in complex with 2-5A	0.166	297	183	9	305	321	541	2.528E-07	197
LOKIASV2_0185_ESMFold_hypothetical_protein	4kin-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4kin-assembly1.cif.gz_A Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 5-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-2-THIOPHENECARBOXAMIDE	0.174	289	237	8	295	5	293	8.525E-08	194
LOKIASV2_0185_ESMFold_hypothetical_protein	6cfm-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6cfm-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a propynyl-pteridinone inhibitor	0.103	297	248	4	300	1	278	1.550E-07	191
LOKIASV2_0185_ESMFold_hypothetical_protein	4o1o-assembly2.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4o1o-assembly2.cif.gz_C Crystal Structure of RNase L in complex with 2-5A	0.163	287	179	16	302	326	540	4.854E-07	189
LOKIASV2_0185_ESMFold_hypothetical_protein	3alo-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3alo-assembly1.cif.gz_A Crystal structure of human non-phosphorylated MKK4 kinase domain ternary complex with AMP-PNP and p38 peptide	0.155	291	237	16	306	8	289	3.906E-07	184
LOKIASV2_0185_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H	LOKIASV2_0185_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.160	272	171	16	287	7	211	1.158E-06	179
LOKIASV2_0185_ESMFold_hypothetical_protein	3oht-assembly1.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3oht-assembly1.cif.gz_B Crystal Structure of Salmo Salar p38alpha	0.182	297	238	8	304	6	297	1.247E-07	177
LOKIASV2_0185_ESMFold_hypothetical_protein	6dfl-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	6dfl-assembly1.cif.gz_A WaaP in complex with acyl carrier protein	0.132	281	181	20	300	28	237	4.598E-07	169
LOKIASV2_0185_ESMFold_hypothetical_protein	4jon-assembly3.cif.gz_C	LOKIASV2_0185_ESMFold_hypothetical_protein	4jon-assembly3.cif.gz_C Crystal structure of a centrosomal protein 170kDa, transcript variant beta (CEP170) from Homo sapiens at 2.15 A resolution (PSI Community Target, Sundstrom)	0.115	132	96	312	443	4	112	2.658E-04	156
LOKIASV2_0185_ESMFold_hypothetical_protein	5ukf-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	5ukf-assembly2.cif.gz_B Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	0.101	249	222	56	304	13	260	6.247E-06	155
LOKIASV2_0185_ESMFold_hypothetical_protein	5ukf-assembly4.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	5ukf-assembly4.cif.gz_D Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	0.100	259	231	46	304	6	263	3.369E-05	148
LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_D	LOKIASV2_0185_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G4998	0.229	160	106	9	168	62	200	2.963E-04	138
LOKIASV2_0185_ESMFold_hypothetical_protein	6hc1-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	6hc1-assembly2.cif.gz_B Bdellovibrio bacteriovorus DgcB FHA in complex with phosphorylated N-terminal peptide	0.149	122	83	313	434	2	99	4.739E-03	129
LOKIASV2_0185_ESMFold_hypothetical_protein	3els-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3els-assembly1.cif.gz_A Crystal Structure of Yeast Pml1p, Residues 51-204	0.130	135	113	302	436	15	145	8.787E-04	127
LOKIASV2_0185_ESMFold_hypothetical_protein	2csw-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2csw-assembly1.cif.gz_A Solution structure of the FHA domain of human ubiquitin ligase protein RNF8	0.134	132	102	311	442	15	133	1.153E-03	123
LOKIASV2_0185_ESMFold_hypothetical_protein	4h87-assembly2.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	4h87-assembly2.cif.gz_A Crystal structure of a FHA domain of kanadaptin (SLC4A1AP) from Homo sapiens at 1.55 A resolution	0.145	125	91	310	434	17	123	3.239E-03	115
LOKIASV2_0185_ESMFold_hypothetical_protein	3elv-assembly2.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	3elv-assembly2.cif.gz_B Crystal Structure of Full-Length Yeast Pml1p	0.143	135	111	302	436	15	144	3.239E-03	114
LOKIASV2_0185_ESMFold_hypothetical_protein	4h87-assembly3.cif.gz_B	LOKIASV2_0185_ESMFold_hypothetical_protein	4h87-assembly3.cif.gz_B Crystal structure of a FHA domain of kanadaptin (SLC4A1AP) from Homo sapiens at 1.55 A resolution	0.136	125	91	310	434	17	122	3.420E-03	112
LOKIASV2_0185_ESMFold_hypothetical_protein	3vpy-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3vpy-assembly1.cif.gz_A Crystal structure of Arabidopsis DDL FHA domain	0.108	131	109	312	442	15	137	1.881E-03	112
LOKIASV2_0185_ESMFold_hypothetical_protein	2jpe-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2jpe-assembly1.cif.gz_A FHA domain of NIPP1	0.141	124	88	313	436	26	129	4.488E-03	106
LOKIASV2_0185_ESMFold_hypothetical_protein	7dco-assembly1.cif.gz_Y	LOKIASV2_0185_ESMFold_hypothetical_protein	7dco-assembly1.cif.gz_Y Cryo-EM structure of the activated spliceosome (Bact complex) at an atomic resolution of 2.5 angstrom	0.135	135	112	302	436	44	174	3.813E-03	97
LOKIASV2_0185_ESMFold_hypothetical_protein	5z57-assembly1.cif.gz_X	LOKIASV2_0185_ESMFold_hypothetical_protein	5z57-assembly1.cif.gz_X Cryo-EM structure of the human activated spliceosome (late Bact) at 6.5 angstrom	0.128	149	104	289	437	38	157	5.578E-03	95
LOKIASV2_0185_ESMFold_hypothetical_protein	2n84-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2n84-assembly1.cif.gz_A Solution structure of the FHA domain of TbPar42	0.142	123	87	313	435	72	173	4.251E-03	95
LOKIASV2_0185_ESMFold_hypothetical_protein	5z58-assembly1.cif.gz_X	LOKIASV2_0185_ESMFold_hypothetical_protein	5z58-assembly1.cif.gz_X Cryo-EM structure of a human activated spliceosome (early Bact) at 4.9 angstrom.	0.134	149	103	289	437	38	157	6.219E-03	90
LOKIASV2_0185_ESMFold_hypothetical_protein	5z56-assembly1.cif.gz_X	LOKIASV2_0185_ESMFold_hypothetical_protein	5z56-assembly1.cif.gz_X cryo-EM structure of a human activated spliceosome (mature Bact) at 5.1 angstrom.	0.155	149	101	289	437	38	158	9.098E-03	84
LOKIASV2_0185_ESMFold_hypothetical_protein	2pu8-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	2pu8-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.113	354	244	20	295	19	372	6.342E-04	79
LOKIASV2_0185_ESMFold_hypothetical_protein	3hue-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3hue-assembly1.cif.gz_A Structure of the S. pombe Nbs1 FHA-BRCT1-BRCT2 domains	0.089	66	51	379	435	50	115	1.305E-01	67
LOKIASV2_0185_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A	LOKIASV2_0185_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A Crystal structure of Rv3168 with ATP	0.085	335	263	4	291	14	348	1.713E-01	39
